Xeroderma
Xeroderma Pigmentosum
Dana Nasser
http://courses.csusm.edu
Xeroderma Pigmentosum, XPF and Nucleotide Excision Repair
By Crystal Stanford
http://courses.bio.unc.edu
PROGERIA (Hutchinson-Guilford syndrome)
http://web.campbell.edu
DNA REPAIR
http://www.columbia.edu
Xeroderma Pigmentosum
Diana Mok, Kaitlin Myers, Thao Nguyen T. Nguyen
http://academics.hamilton.edu
Effective Professional Presentation Skills
Nancy Clark, M.Ed.
http://med.fsu.edu
DNA Repair and Cancer
http://ww2.biol.sc.edu
DNA Repair Types
http://www.pharmacy.umn.edu
Melanoma
Alan L. Cowan, Anna M. Pou
http://www.utmb.edu
Children of the Moon - Xeroderma Pigmentosum (XP)
Dayleen Coleman
http://courses.csusm.edu
DNA Damage and Repair
http://www.faculty.biol.ttu.
422 free full text published articles on Xeroderma
1. Singh UR, Asif S, Kommu PP, D'Souza P. Cockayne syndrome-xeroderma pigmentosum complex with demyelination. A rare association. Indian J Hum Genet. 2012 Jan;18(1).125-6.
2. Ueda T, Kanda F, Aoyama N, Fujii M, Nishigori C, Toda T. Neuroimaging features of xeroderma pigmentosum group A. Brain Behav. 2012 Jan;2(1).1-5.
3. Kassubek J, Sperfeld AD, Pinkhardt EH, Unrath A, Müller HP, Scharffetter-Kochanek K, Ludolph AC, Berneburg M. The cerebro-morphological fingerprint of a progeroid syndrome. white matter changes correlate with neurological symptoms in xeroderma pigmentosum. PLoS One. 2012;7(2).e30926. Epub 2012 Feb 21.
4. Ben Rekaya M, Messaoud O, Mebazaa A, Riahi O, Azaiez H, Kefi R, Zghal M, Boubaker S, Amouri A, Ben Osman-Dhahri A, Abdelhak S, Mokni M. A novel POLH gene mutation in a xeroderma pigmentosum-V Tunisian patient. phenotype-genotype correlation. J Genet. 2011 Dec;90(3).483-7.
5. Viana Fde O, Cavaleiro LH, Carneiro CM, Bittencourt Mde J, Barros RS, Fonseca DM. Do you know this syndrome? Xeroderma pigmentosum (XP). An Bras Dermatol. 2011 Sep-Oct;86(5).1029. English, Portuguese.
6. Lehmann AR, McGibbon D, Stefanini M. Xeroderma pigmentosum. Orphanet J Rare Dis. 2011 Nov 1;6.70. Review.
7. Grampurohit VU, Dinesh US, Rao R. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum. J Cancer Res Ther. 2011 Apr-Jun;7(2).205-7.
8. Ramkumar HL, Brooks BP, Cao X, Tamura D, Digiovanna JJ, Kraemer KH, Chan CC. Ophthalmic manifestations and histopathology of xeroderma pigmentosum. two clinicopathological cases and a review of the literature. Surv Ophthalmol. 2011 Jul-Aug;56(4).348-61. doi. 10.1016/j.survophthal.2011.03.001. Review.
9. Rezvani HR, Taïeb A. [Xeroderma pigmentosum. a useful model to study the relation between genomic mutations and cell transformation]. Med Sci (Paris). 2011 May;27(5).467-70. Epub 2011 May 25. French.
10. Orosco RK, Wang T, Byrne PJ. Xeroderma pigmentosum in an African-American. ORL J Otorhinolaryngol Relat Spec. 2011;73(3).162-5. Epub 2011 May 11.
11. Ming M, Shea CR, Guo X, Li X, Soltani K, Han W, He YY. Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C. Proc Natl Acad Sci U S A. 2010 Dec 28;107(52).22623-8. Epub 2010 Dec 13.
12. Saijo M, Takedachi A, Tanaka K. Nucleotide excision repair by mutant xeroderma pigmentosum group A (XPA) proteins with deficiency in interaction with RPA. J Biol Chem. 2011 Feb 18;286(7).5476-83. Epub 2010 Dec 9.
13. Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J, Oh KS, Imoto K, Inui H, Moriwaki S, Emmert S, Pike KM, Raziuddin A, Plona TM, DiGiovanna JJ, Tucker MA, Kraemer KH. Cancer and neurologic degeneration in xeroderma pigmentosum. long term follow-up characterises the role of DNA repair. J Med Genet. 2011 Mar;48(3).168-76. Epub 2010 Nov 19.
14. Wu YH, Wu TC, Liao JW, Yeh KT, Chen CY, Lee H. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression. Cancer Res. 2010 Dec 15;70(24).10422-32. Epub 2010 Nov 5.
15. Mane DR, Kale AD, Hallikerimath S, Angadi P, Kotrashetti V. Trichilemmal carcinoma associated with xeroderma pigmentosa. report of a rare case. J Oral Sci. 2010 Sep;52(3).505-7.
16. Mathieu N, Kaczmarek N, Naegeli H. Strand- and site-specific DNA lesion demarcation by the xeroderma pigmentosum group D helicase. Proc Natl Acad Sci U S A. 2010 Oct 12;107(41).17545-50. Epub 2010 Sep 27.
17. Krasikova YS, Rechkunova NI, Maltseva EA, Petruseva IO, Lavrik OI. Localization of xeroderma pigmentosum group A protein and replication protein A on damaged DNA in nucleotide excision repair. Nucleic Acids Res. 2010 Dec;38(22).8083-94. Epub 2010 Aug 6.
18. El Ouazzani Chahdi K, Karim A, Salhi Y, Melhaoui A, Daoudi R. [Xeroderma pigmentosum associated with intracerebral tumor. a case report]. J Fr Ophtalmol. 2010 Sep;33(7).495.e1-4. Epub 2010 Jul 31. French.
19. Amin A, Bassiouny M, Sallam K, Ghally G, El-Karaksy H, El-Haddad A. Living related hemi-face skin transplant using radial forearm free flap for a xeroderma pigmentosa patient. early outcome. Head Neck Oncol. 2010 Jul 13;2.18.
20. Takahashi Y, Endo Y, Sugiyama Y, Inoue S, Iijima M, Tomita Y, Kuru S, Takigawa M, Moriwaki S. XPA gene mutations resulting in subtle truncation of protein in xeroderma pigmentosum group A patients with mild skin symptoms. J Invest Dermatol. 2010 Oct;130(10).2481-8. Epub 2010 Jun 24.
21. Wei CC, Sanfilippo NJ, Myssiorek D. Re-irradiation of metastatic disease in the neck from xeroderma pigmentosum. Curr Oncol. 2010 Jun;17(3).83-5.
22. García M, Llames S, García E, Meana A, Cuadrado N, Recasens M, Puig S, Nagore E, Illera N, Jorcano JL, Del Rio M, Larcher F. In vivo assessment of acute UVB responses in normal and Xeroderma Pigmentosum (XP-C) skin-humanized mouse models. Am J Pathol. 2010 Aug;177(2).865-72. Epub 2010 Jun 17.
23. Guthrie OW, Carrero-Martínez FA. Real-time quantification of Xeroderma pigmentosum mRNA from the mammalian cochlea. Ear Hear. 2010 Oct;31(5).714-21.
24. Tamura D, DiGiovanna JJ, Kraemer KH. Founder mutations in xeroderma pigmentosum. J Invest Dermatol. 2010 Jun;130(6).1491-3.
25. Barron GS, Kirsner RS. Xeroderma pigmentosum. a heterogeneous disease with pockets of homogeneity. J Invest Dermatol. 2010 Jun;130(6).1484.
26. Dong L, Wen J, Pier E, Zhang X, Zhang B, Dong F, Ziegler N, Mysz M, Armenta R, Cui R. Melanocyte-stimulating hormone directly enhances UV-Induced DNA repair in keratinocytes by a xeroderma pigmentosum group A-dependent mechanism. Cancer Res. 2010 May 1;70(9).3547-56. Epub 2010 Apr 13.
27. Kraemer KH, DiGiovanna JJ. Xeroderma Pigmentosum. 2003 Jun 20 [updated 2012 Mar 15]. In. Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. GeneReviews™ [Internet]. Seattle (WA). University of Washington, Seattle; 1993-. Available from http.//www.ncbi.nlm.nih.gov/books/NBK1397/
28. Al-Niaimi F, Cox NH. An unusual presentation of xeroderma pigmentosum in a Caucasian child. Eur J Dermatol. 2010 May-Jun;20(3).386-7. Epub 2010 Feb 5.
29. Soufir N, Ged C, Bourillon A, Austerlitz F, Chemin C, Stary A, Armier J, Pham D, Khadir K, Roume J, Hadj-Rabia S, Bouadjar B, Taieb A, de Verneuil H, Benchiki H, Grandchamp B, Sarasin A. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. J Invest Dermatol. 2010 Jun;130(6).1537-42. Epub 2010 Jan 7.
30. Henry S, Christiansen D, Kazmier F, Besch-Williford C, Concannon M. The protective effect of amifostine on ultraviolet B-exposed xeroderma pigmentosum mice. Ecancermedicalscience. 2010;4.176. Epub 2010 Sep 22.
31. Wang Y, Tan XH, DiGiovanna JJ, Lee CC, Stern JB, Raffeld M, Jaffe ES, Kraemer KH. Genetic diversity in melanoma metastases from a patient with xeroderma pigmentosum. J Invest Dermatol. 2010 Apr;130(4).1188-91. Epub 2009 Dec 3.
32. Khan SG, Yamanegi K, Zheng ZM, Boyle J, Imoto K, Oh KS, Baker CC, Gozukara E, Metin A, Kraemer KH. XPC branch-point sequence mutations disrupt U2 snRNP binding, resulting in abnormal pre-mRNA splicing in xeroderma pigmentosum patients. Hum Mutat. 2010 Feb;31(2).167-75.
33. Ueda T, Compe E, Catez P, Kraemer KH, Egly JM. Both XPD alleles contribute to the phenotype of compound heterozygote xeroderma pigmentosum patients. J Exp Med. 2009 Dec 21;206(13).3031-46. Epub 2009 Nov 23.
34. Rao TN, Bhagyalaxmi A, Ahmed K, Mohana Rao TS, Venkatachalam K. A case of melanoma in xeroderma pigmentosum. Indian J Pathol Microbiol. 2009 Oct-Dec;52(4).524-6.
35. Abbaszadeh F, Clingen PH, Arlett CF, Plowman PN, Bourton EC, Themis M, Makarov EM, Newbold RF, Green MH, Parris CN. A novel splice variant of the DNA-PKcs gene is associated with clinical and cellular radiosensitivity in a patient with xeroderma pigmentosum. J Med Genet. 2010 Mar;47(3).176-81. Epub 2009 Sep 24.
36. Monaco R, Rosal R, Dolan MA, Pincus MR, Freyer G, Brandt-Rauf PW. Conformational effects of a common codon 751 polymorphism on the C-terminal domain of the xeroderma pigmentosum D protein. J Carcinog. 2009;8.12.
37. Camenisch U, Träutlein D, Clement FC, Fei J, Leitenstorfer A, Ferrando-May E, Naegeli H. Two-stage dynamic DNA quality check by xeroderma pigmentosum group C protein. EMBO J. 2009 Aug 19;28(16).2387-99. Epub 2009 Jul 16.
38. Shell SM, Li Z, Shkriabai N, Kvaratskhelia M, Brosey C, Serrano MA, Chazin WJ, Musich PR, Zou Y. Checkpoint kinase ATR promotes nucleotide excision repair of UV-induced DNA damage via physical interaction with xeroderma pigmentosum group A. J Biol Chem. 2009 Sep 4;284(36).24213-22. Epub 2009 Jul 8.
39. Wang Y, Digiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, Oh KS, Hollander MC, Dennis PA, Kraemer KH. Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci U S A. 2009 Apr 14;106(15).6279-84. Epub 2009 Mar 27.
40. Wang LN, Ma MJ, Shi JT. Malignant neurilemoma with xeroderma pigmentosum. BMJ Case Rep. 2009;2009. pii. bcr06.2008.0127. Epub 2009 Apr 7.
41. Andressoo JO, Weeda G, de Wit J, Mitchell JR, Beems RB, van Steeg H, van der Horst GT, Hoeijmakers JH. An Xpb mouse model for combined xeroderma pigmentosum and cockayne syndrome reveals progeroid features upon further attenuation of DNA repair. Mol Cell Biol. 2009 Mar;29(5).1276-90. Epub 2008 Dec 29.
42. Rubió Casadevall J, Graña-Suárez B, Hernandez-Yagüe X, Vayreda Ribera J, Huc Grasa O, Brunet Vidal J. Xeroderma pigmentosum. neck lymph node metastasis of a squamous cell carcinoma of the skin treated with cetuximab. Eur J Dermatol. 2009 Mar-Apr;19(2).163-5. Epub 2008 Dec 23.
43. Arora R, Sharma A, Gupta R, Vijayaraghavan M. Cutaneous angiosarcoma in a patient with xeroderma pigmentosum. Indian J Pathol Microbiol. 2008 Oct-Dec;51(4).504-6.
44. Khan SG, Oh KS, Emmert S, Imoto K, Tamura D, Digiovanna JJ, Shahlavi T, Armstrong N, Baker CC, Neuburg M, Zalewski C, Brewer C, Wiggs E, Schiffmann R, Kraemer KH. XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms. DNA Repair (Amst). 2009 Jan 1;8(1).114-25. Epub 2008 Nov 14.
45. Halpern J, Hopping B, Brostoff JM. Photosensitivity, corneal scarring and developmental delay. Xeroderma Pigmentosum in a tropical country. Cases J. 2008 Oct 20;1(1).254.
46. Rizvi SA, Amitava AK, Mehdi G, Sharma R, Alam MS. Orbital amelanotic melanoma in xeroderma pigmentosum. a rare association. Indian J Ophthalmol. 2008 Sep-Oct;56(5).421-3.
47. Fan W, Luo J. RecQ4 facilitates UV light-induced DNA damage repair through interaction with nucleotide excision repair factor xeroderma pigmentosum group A (XPA). J Biol Chem. 2008 Oct 24;283(43).29037-44. Epub 2008 Aug 7.
48. Ezzedine K, Simonart T, Candaele M, Malvy D, Heenen M. Concomitant Xeroderma pigmentosum and disseminated small plaque psoriasis. first case of an antinomic association. Cases J. 2008 Aug 7;1(1).74.
49. Taylor AM. Neurodegeneration in xeroderma pigmentosum. Brain. 2008 Aug;131(Pt 8).1967-8. Epub 2008 Jul 18.
50. Emmert S, Ueda T, Zumsteg U, Weber P, Khan SG, Oh KS, Boyle J, Laspe P, Zachmann K, Boeckmann L, Kuschal C, Bircher A, Kraemer KH. Strict sun protection results in minimal skin changes in a patient with xeroderma pigmentosum and a novel c.2009delG mutation in XPD (ERCC2). Exp Dermatol. 2009 Jan;18(1).64-8. Epub 2008 Jul 7.
51. Anttinen A, Koulu L, Nikoskelainen E, Portin R, Kurki T, Erkinjuntti M, Jaspers NG, Raams A, Green MH, Lehmann AR, Wing JF, Arlett CF, Marttila RJ. Neurological symptoms and natural course of xeroderma pigmentosum. Brain. 2008 Aug;131(Pt 8).1979-89. Epub 2008 Jun 21.
52. Brooks PJ. The 8,5'-cyclopurine-2'-deoxynucleosides. candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair. DNA Repair (Amst). 2008 Jul 1;7(7).1168-79. Epub 2008 May 20. Review.
53. Inui H, Oh KS, Nadem C, Ueda T, Khan SG, Metin A, Gozukara E, Emmert S, Slor H, Busch DB, Baker CC, DiGiovanna JJ, Tamura D, Seitz CS, Gratchev A, Wu WH, Chung KY, Chung HJ, Azizi E, Woodgate R, Schneider TD, Kraemer KH. Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol. 2008 Aug;128(8).2055-68. Epub 2008 Mar 27.
54. Cleaver JE, Revet I. Clinical implications of the basic defects in Cockayne syndrome and xeroderma pigmentosum and the DNA lesions responsible for cancer, neurodegeneration and aging. Mech Ageing Dev. 2008 Jul-Aug;129(7-8).492-7. Epub 2008 Feb 3.
55. Melis JP, Wijnhoven SW, Beems RB, Roodbergen M, van den Berg J, Moon H, Friedberg E, van der Horst GT, Hoeijmakers JH, Vijg J, van Steeg H. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes. Cancer Res. 2008 Mar 1;68(5).1347-53.
56. Webb S. Xeroderma pigmentosum. BMJ. 2008 Feb 23;336(7641).444-6. Review.
57. Sugasawa K. Xeroderma pigmentosum genes. functions inside and outside DNA repair. Carcinogenesis. 2008 Mar;29(3).455-65. Epub 2008 Jan 3.
58. Cleaver JE. Diagnosis of Xeroderma Pigmentosum and Related DNA Repair-Deficient Cutaneous Diseases. Curr Med Lit Dermatol. 2008;13(2).41-48.
59. Arlett CF, Green MH, Rogers PB, Lehmann AR, Plowman PN. Minimal ionizing radiation sensitivity in a large cohort of xeroderma pigmentosum fibroblasts. Br J Radiol. 2008 Jan;81(961).51-8.
60. Shen J, Gammon MD, Terry MB, Teitelbaum SL, Eng SM, Neugut AI, Santella RM. Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk. Eur J Cancer. 2008 Mar;44(5).710-7. Epub 2007 Nov 28.
61. Lu CC, Chen YC, Wang JT, Yang PW, Chen MR. Xeroderma pigmentosum C is involved in Epstein Barr virus DNA replication. J Gen Virol. 2007 Dec;88(Pt 12).3234-43.
62. Stoyanova T, Yoon T, Kopanja D, Mokyr MB, Raychaudhuri P. The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21Waf1/Cip1. Mol Cell Biol. 2008 Jan;28(1).177-87. Epub 2007 Oct 29.
63. Yoneda K, Moriue J, Matsuoka Y, Moriwaki S, Moriue T, Nakai K, Yokoi I, Nibu N, Demitsu T, Kubota Y. Xeroderma pigmentosum complementation group G in association with malignant melanoma. Eur J Dermatol. 2007 Nov-Dec;17(6).540-1. Epub 2007 Oct 19.
64. Hashimoto S, Egawa K, Ihn H, Igarashi A, Matsunaga T, Tateishi S, Yamaizumi M. A new disorder in UV-induced skin cancer with defective DNA repair distinct from xeroderma pigmentosum or Cockayne syndrome. J Invest Dermatol. 2008 Mar;128(3).694-701. Epub 2007 Oct 11.
65. Liu Y, Wang Y, Rusinol AE, Sinensky MS, Liu J, Shell SM, Zou Y. Involvement of xeroderma pigmentosum group A (XPA) in progeria arising from defective maturation of prelamin A. FASEB J. 2008 Feb;22(2).603-11. Epub 2007 Sep 11.
66. Wang QE, Praetorius-Ibba M, Zhu Q, El-Mahdy MA, Wani G, Zhao Q, Qin S, Patnaik S, Wani AA. Ubiquitylation-independent degradation of Xeroderma pigmentosum group C protein is required for efficient nucleotide excision repair. Nucleic Acids Res. 2007;35(16).5338-50. Epub 2007 Aug 9.
67. Yasuda G, Nishi R, Watanabe E, Mori T, Iwai S, Orioli D, Stefanini M, Hanaoka F, Sugasawa K. In vivo destabilization and functional defects of the xeroderma pigmentosum C protein caused by a pathogenic missense mutation. Mol Cell Biol. 2007 Oct;27(19).6606-14. Epub 2007 Aug 6.
68. Mohanty P, Mohanty L, Devi BP. Multiple cutaneous malignancies in xeroderma pigmentosum. Indian J Dermatol Venereol Leprol. 2001 Mar-Apr;67(2).96-7.
69. Ramachandra L, Rajagopal Shenoi K, Santhosh Pai U. Xeroderma pigmentosa in siblings. cystosarcoma phylloides in a case of xeroderma pigmentosa. Indian J Dermatol Venereol Leprol. 2002 May-Jun;68(3).168-70.
70. Adair JE, Maloney SC, Dement GA, Wertzler KJ, Smerdon MJ, Reeves R. High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A. Cancer Res. 2007 Jul 1;67(13).6044-52.
71. Yang G, Curley D, Bosenberg MW, Tsao H. Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice. Cancer Res. 2007 Jun 15;67(12).5649-57.
72. Patil MR, Vishwanath V, Arya M, Shenoy BP, Bharmal RN, Torsekar RG. Pilomatricoma in a case of familial xeroderma pigmentosum. Indian J Dermatol Venereol Leprol. 2007 May-Jun;73(3).198-9.
73. Miccoli L, Burr KL, Hickenbotham P, Friedberg EC, Angulo JF, Dubrova YE. The combined effects of xeroderma pigmentosum C deficiency and mutagens on mutation rates in the mouse germ line. Cancer Res. 2007 May 15;67(10).4695-9.
74. Chen Z, Yang J, Wang G, Song B, Li J, Xu Z. Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression. Cancer Res. 2007 May 15;67(10).4578-85.
75. Wang Y, Woodgate R, McManus TP, Mead S, McCormick JJ, Maher VM. Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations. Cancer Res. 2007 Apr 1;67(7).3018-26.
76. Tanioka M, Masaki T, Ono R, Nagano T, Otoshi-Honda E, Matsumura Y, Takigawa M, Inui H, Miyachi Y, Moriwaki S, Nishigori C. Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type. J Invest Dermatol. 2007 Jul;127(7).1745-51. Epub 2007 Mar 8.
77. Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome. a complex genotype-phenotype relationship. Neuroscience. 2007 Apr 14;145(4).1388-96. Epub 2007 Feb 1. Review.
78. Brooks PJ. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience. 2007 Apr 14;145(4).1407-17. Epub 2006 Dec 19. Review.
79. Snyder SH. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G. implications for a second XPG function. Proc Natl Acad Sci U S A. 2006 Dec 19;103(51).19606. Epub 2006 Dec 13.
80. Yang Z, Roginskaya M, Colis LC, Basu AK, Shell SM, Liu Y, Musich PR, Harris CM, Harris TM, Zou Y. Specific and efficient binding of xeroderma pigmentosum complementation group A to double-strand/single-strand DNA junctions with 3'- and/or 5'-ssDNA branches. Biochemistry. 2006 Dec 26;45(51).15921-30. Epub 2006 Dec 19.
81. Bunick CG, Miller MR, Fuller BE, Fanning E, Chazin WJ. Biochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein. Biochemistry. 2006 Dec 19;45(50).14965-79.
82. Wen SX, Tang PZ, Zhang XM, Zhao D, Guo YL, Tan W, Lin DX. [Association between genetic polymorphism in xeroderma pigmentosum G gene and risks of laryngeal and hypopharyngeal carcinomas]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Oct;28(5).703-6. Chinese.
83. Zárate RN, Arias F, Bandres E, Cubedo E, Malumbres R, García-Foncillas J. Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy. World J Gastroenterol. 2006 Oct 7;12(37).6032-6.
84. Cleaver JE, Feeney L, Tang JY, Tuttle P. Xeroderma pigmentosum group C in an isolated region of Guatemala. J Invest Dermatol. 2007 Feb;127(2).493-6. Epub 2006 Sep 21.
85. Arlett CF, Plowman PN, Rogers PB, Parris CN, Abbaszadeh F, Green MH, McMillan TJ, Bush C, Foray N, Lehmann AR. Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum. Br J Radiol. 2006 Jun;79(942).510-7.
86. Booton R, Ward T, Heighway J, Taylor P, Power F, Ashcroft L, Morris J, Thatcher N. Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer. Cancer. 2006 Jun 1;106(11).2421-7.
87. Thompson JR, Ryan ZC, Salisbury JL, Kumar R. The structure of the human centrin 2-xeroderma pigmentosum group C protein complex. J Biol Chem. 2006 Jul 7;281(27).18746-52. Epub 2006 Apr 20.
88. Wu X, Shell SM, Yang Z, Zou Y. Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation. Cancer Res. 2006 Mar 15;66(6).2997-3005.
89. Kapetanaki MG, Guerrero-Santoro J, Bisi DC, Hsieh CL, Rapić-Otrin V, Levine AS. The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites. Proc Natl Acad Sci U S A. 2006 Feb 21;103(8).2588-93. Epub 2006 Feb 10.
90. Liu G, Chen X. DNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation. Mol Cell Biol. 2006 Feb;26(4).1398-413. Erratum in. Mol Cell Biol. 2006 May;26(9).3680.
91. Chowdhury RK, Padhi T, Das GS. Keratoacanthoma of the conjunctiva complicating xeroderma pigmentosum. Indian J Dermatol Venereol Leprol. 2005 Nov-Dec;71(6).430-1.
92. Bowden NA, Tooney PA, Scott RJ. Gene expression profiling of xeroderma pigmentosum. Hered Cancer Clin Pract. 2006 May 15;4(2).103-10.
93. Kulaksiz G, Reardon JT, Sancar A. Xeroderma pigmentosum complementation group E protein (XPE/DDB2). purification of various complexes of XPE and analyses of their damaged DNA binding and putative DNA repair properties. Mol Cell Biol. 2005 Nov;25(22).9784-92.
94. Wittschieben BØ, Iwai S, Wood RD. DDB1-DDB2 (xeroderma pigmentosum group E) protein complex recognizes a cyclobutane pyrimidine dimer, mismatches, apurinic/apyrimidinic sites, and compound lesions in DNA. J Biol Chem. 2005 Dec 2;280(48).39982-9. Epub 2005 Aug 24.
95. Theron T, Fousteri MI, Volker M, Harries LW, Botta E, Stefanini M, Fujimoto M, Andressoo JO, Mitchell J, Jaspers NG, McDaniel LD, Mullenders LH, Lehmann AR. Transcription-associated breaks in xeroderma pigmentosum group D cells from patients with combined features of xeroderma pigmentosum and Cockayne syndrome. Mol Cell Biol. 2005 Sep;25(18).8368-78.
96. Itoh T, Miyauchi-Hashimoto H, Sugihara A, Tanaka K, Horio T. The photocarcinogenesis of antibiotic lomefloxacin and UVA radiation is enhanced in xeroderma pigmentosum group A gene-deficient mice. J Invest Dermatol. 2005 Sep;125(3).554-9.
97. Yamazaki F, Okamoto H, Matsumura Y, Tanaka K, Kunisada T, Horio T. Development of a new mouse model (xeroderma pigmentosum a-deficient, stem cell factor-transgenic) of ultraviolet B-induced melanoma. J Invest Dermatol. 2005 Sep;125(3).521-5.
98. Khan SG, Oh KS, Shahlavi T, Ueda T, Busch DB, Inui H, Emmert S, Imoto K, Muniz-Medina V, Baker CC, DiGiovanna JJ, Schmidt D, Khadavi A, Metin A, Gozukara E, Slor H, Sarasin A, Kraemer KH. Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients. Carcinogenesis. 2006 Jan;27(1).84-94. Epub 2005 Aug 4.
99. Kuschel B, Chenevix-Trench G, Spurdle AB, Chen X, Hopper JL, Giles GG, McCredie M, Chang-Claude J, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, Pharoah PD. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7).1828-31.
100. Alymlahi E, Dafiri R. Bilateral facial squamous cell carcinoma in an 18-month-old girl with xeroderma pigmentosum. J Postgrad Med. 2005 Apr-Jun;51(2).128-30.
101. Nishi R, Okuda Y, Watanabe E, Mori T, Iwai S, Masutani C, Sugasawa K, Hanaoka F. Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein. Mol Cell Biol. 2005 Jul;25(13).5664-74.
102. Miyauchi-Hashimoto H, Sugihara A, Tanaka K, Horio T. Ultraviolet radiation-induced impairment of tumor rejection is enhanced in xeroderma pigmentosum a gene-deficient mice. J Invest Dermatol. 2005 Jun;124(6).1313-7.
103. Stevens EV, Raffeld M, Espina V, Kristensen GB, Trope' CG, Kohn EC, Davidson B. Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma. Cancer. 2005 Jun 1;103(11).2313-9.
104. Fan W, Zhang HL, Wu XM. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin]. Ai Zheng. 2005 Apr;24(4).403-7. Chinese.
105. Blankenburg S, König IR, Moessner R, Laspe P, Thoms KM, Krueger U, Khan SG, Westphal G, Berking C, Volkenandt M, Reich K, Neumann C, Ziegler A, Kraemer KH, Emmert S. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma. a case-control study. Carcinogenesis. 2005 Jun;26(6).1085-90. Epub 2005 Feb 24.
106. Lam CW, Cheung KK, Luk NM, Chan SW, Lo KK, Tong SF. DNA-based diagnosis of xeroderma pigmentosum group C by Whole-genome scan using single-nucleotide polymorphism microarray. J Invest Dermatol. 2005 Jan;124(1).87-91.
107. Marchetto MC, Muotri AR, Burns DK, Friedberg EC, Menck CF. Gene transduction in skin cells. preventing cancer in xeroderma pigmentosum mice. Proc Natl Acad Sci U S A. 2004 Dec 21;101(51).17759-64. Epub 2004 Dec 14.
108. Blankenburg S, König IR, Moessner R, Laspe P, Thoms KM, Krueger U, Khan SG, Westphal G, Volkenandt M, Neumann C, Ziegler A, Kraemer KH, Reich K, Emmert S. No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma. Eur J Hum Genet. 2005 Feb;13(2).253-5.
109. Couvé-Privat S, Le Bret M, Traiffort E, Queille S, Coulombe J, Bouadjar B, Avril MF, Ruat M, Sarasin A, Daya-Grosjean L. Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients. Cancer Res. 2004 May 15;64(10).3559-65.
110. Tian M, Jones DA, Smith M, Shinkura R, Alt FW. Deficiency in the nuclease activity of xeroderma pigmentosum G in mice leads to hypersensitivity to UV irradiation. Mol Cell Biol. 2004 Mar;24(6).2237-42.
111. Chen Z, Xu XS, Harrison J, Wang G. Defining the function of xeroderma pigmentosum group F protein in psoralen interstrand cross-link-mediated DNA repair and mutagenesis. Biochem J. 2004 Apr 1;379(Pt 1).71-8.
112. Arbault S, Sojic N, Bruce D, Amatore C, Sarasin A, Vuillaume M. Oxidative stress in cancer prone xeroderma pigmentosum fibroblasts. Real-time and single cell monitoring of superoxide and nitric oxide production with microelectrodes. Carcinogenesis. 2004 Apr;25(4).509-15. Epub 2003 Dec 19.
113. Wu X, Fan W, Xu S, Zhou Y. Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosun group A antisense RNA in human lung adenocarcinoma cells. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1).5874-9.
114. Khan SG, Metin A, Gozukara E, Inui H, Shahlavi T, Muniz-Medina V, Baker CC, Ueda T, Aiken JR, Schneider TD, Kraemer KH. Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene. mutations result in reduced XPC mRNA levels that correlate with cancer risk. Hum Mol Genet. 2004 Feb 1;13(3).343-52. Epub 2003 Dec 8.
115. Ide F, Kitada M, Sakashita H, Kusama K, Tanaka K, Ishikawa T. p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene. Am J Pathol. 2003 Nov;163(5).1729-33.
116. Itoh T, O'Shea C, Linn S. Impaired regulation of tumor suppressor p53 caused by mutations in the xeroderma pigmentosum DDB2 gene. mutual regulatory interactions between p48(DDB2) and p53. Mol Cell Biol. 2003 Nov;23(21).7540-53.
117. Yang Y, Bu D, Wang K, Tu P, Zhu X. Cloning and expression of xeroderma pigmentosum complementation group A cDNA and the identification of its recombinant protein. Beijing Da Xue Xue Bao. 2003 Aug;35(4).426-8.
118. Rademakers S, Volker M, Hoogstraten D, Nigg AL, Moné MJ, Van Zeeland AA, Hoeijmakers JH, Houtsmuller AB, Vermeulen W. Xeroderma pigmentosum group A protein loads as a separate factor onto DNA lesions. Mol Cell Biol. 2003 Aug;23(16).5755-67.
119. Popescu A, Miron S, Blouquit Y, Duchambon P, Christova P, Craescu CT. Xeroderma pigmentosum group C protein possesses a high affinity binding site to human centrin 2 and calmodulin. J Biol Chem. 2003 Oct 10;278(41).40252-61. Epub 2003 Jul 30.
120. Laposa RR, Feeney L, Cleaver JE. Recapitulation of the cellular xeroderma pigmentosum-variant phenotypes using short interfering RNA for DNA polymerase H. Cancer Res. 2003 Jul 15;63(14).3909-12.
121. Ng JM, Vermeulen W, van der Horst GT, Bergink S, Sugasawa K, Vrieling H, Hoeijmakers JH. A novel regulation mechanism of DNA repair by damage-induced and RAD23-dependent stabilization of xeroderma pigmentosum group C protein. Genes Dev. 2003 Jul 1;17(13).1630-45. Epub 2003 Jun 18.
122. Rivera Peñaranda S, Ortuño Gil C, Vera Lorente M, Iniesta Mompeán R, Cascales Barceló I. [Xeroderma pigmentosum. Two more cases in Spain]. An Pediatr (Barc). 2003 Apr;58(4).402-3. Spanish.
123. Norgauer J, Idzko M, Panther E, Hellstern O, Herouy Y. Xeroderma pigmentosum. Eur J Dermatol. 2003 Jan-Feb;13(1).4-9. Review.
124. Oliveira CR, Elias L, Barros AC, Conceição DB. [Anesthesia in patient with Xeroderma Pigmentosum. case report.]. Rev Bras Anestesiol. 2003 Feb;53(1).46-51. Portuguese.
125. Tang J, Chu G. Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein. DNA Repair (Amst). 2002 Aug 6;1(8).601-16. Review.
126. Shimizu Y, Iwai S, Hanaoka F, Sugasawa K. Xeroderma pigmentosum group C protein interacts physically and functionally with thymine DNA glycosylase. EMBO J. 2003 Jan 2;22(1).164-73.
127. Couvé-Privat S, Bouadjar B, Avril MF, Sarasin A, Daya-Grosjean L. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res. 2002 Dec 15;62(24).7186-9.
128. Soufir N, Ribojad M, Magnaldo T, Thibaudeau O, Delestaing G, Daya-Grosjean L, Rivet J, Sarasin A, Basset-Seguin N. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient. J Invest Dermatol. 2002 Dec;119(6).1355-60.
129. Azzam EI, Nagasawa H, Yu Y, Li CY, Little JB. Cell cycle deregulation and xeroderma pigmentosum group C cell transformation. J Invest Dermatol. 2002 Dec;119(6).1350-4.
130. Negishi I, Kato G, Moriwaki S, Ishikawa O. Compound heterozygosity for the Xeroderma pigmentosum complementation group A gene associated with a mild phenotype. Eur J Dermatol. 2002 Nov-Dec;12(6).536-9.
131. Park JY, Park SH, Choi JE, Lee SY, Jeon HS, Cha SI, Kim CH, Park JH, Kam S, Park RW, Kim IS, Jung TH. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1).993-7.
132. Yavuz S, Yavuz AS, Kraemer KH, Lipsky PE. The role of polymerase eta in somatic hypermutation determined by analysis of mutations in a patient with xeroderma pigmentosum variant. J Immunol. 2002 Oct 1;169(7).3825-30.
133. Adimoolam S, Ford JM. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc Natl Acad Sci U S A. 2002 Oct 1;99(20).12985-90. Epub 2002 Sep 19.
134. Cordeiro-Stone M, Frank A, Bryant M, Oguejiofor I, Hatch SB, McDaniel LD, Kaufmann WK. DNA damage responses protect xeroderma pigmentosum variant from UVC-induced clastogenesis. Carcinogenesis. 2002 Jun;23(6).959-65.
135. Emmert S, Slor H, Busch DB, Batko S, Albert RB, Coleman D, Khan SG, Abu-Libdeh B, DiGiovanna JJ, Cunningham BB, Lee MM, Crollick J, Inui H, Ueda T, Hedayati M, Grossman L, Shahlavi T, Cleaver JE, Kraemer KH. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients. J Invest Dermatol. 2002 Jun;118(6).972-82. Erratum in. J Invest Dermatol. 2003 Jan;120(1).173..
136. Tan T, Chu G. p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice. Mol Cell Biol. 2002 May;22(10).3247-54.
137. Takahashi Y, Nakatsuru Y, Zhang S, Shimizu Y, Kume H, Tanaka K, Ide F, Ishikawa T. Enhanced spontaneous and aflatoxin-induced liver tumorigenesis in xeroderma pigmentosum group A gene-deficient mice. Carcinogenesis. 2002 Apr;23(4).627-33.
138. Itoh T, Linn S. XP43TO, previously classified as xeroderma pigmentosum Group E, should be reclassified as xeroderma pigmentosum variant. J Invest Dermatol. 2001 Dec;117(6).1672-4.
139. Patrick SM, Turchi JJ. Xeroderma pigmentosum complementation group A protein (XPA) modulates RPA-DNA interactions via enhanced complex stability and inhibition of strand separation activity. J Biol Chem. 2002 May 3;277(18).16096-101. Epub 2002 Feb 21.
140. Lalle P, Nouspikel T, Constantinou A, Thorel F, Clarkson SG. The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity. J Invest Dermatol. 2002 Feb;118(2).344-51.
141. Broughton BC, Cordonnier A, Kleijer WJ, Jaspers NG, Fawcett H, Raams A, Garritsen VH, Stary A, Avril MF, Boudsocq F, Masutani C, Hanaoka F, Fuchs RP, Sarasin A, Lehmann AR. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci U S A. 2002 Jan 22;99(2).815-20. Epub 2002 Jan 2.
142. Limoli CL, Giedzinski E, Bonner WM, Cleaver JE. UV-induced replication arrest in the xeroderma pigmentosum variant leads to DNA double-strand breaks, gamma -H2AX formation, and Mre11 relocalization. Proc Natl Acad Sci U S A. 2002 Jan 8;99(1).233-8. Epub 2001 Dec 26.
143. Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei DD, Groshen S, Lenz HJ. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res. 2001 Dec 15;61(24).8654-8.
144. Suzuki H, Kalair W, Shivji GM, Wang B, Toto P, Amerio P, Kraemer KH, Sauder DN. Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts. J Invest Dermatol. 2001 Nov;117(5).1151-5.
145. Broughton BC, Berneburg M, Fawcett H, Taylor EM, Arlett CF, Nardo T, Stefanini M, Menefee E, Price VH, Queille S, Sarasin A, Bohnert E, Krutmann J, Davidson R, Kraemer KH, Lehmann AR. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum Mol Genet. 2001 Oct 15;10(22).2539-47.
146. Itoh T, Nichols A, Linn S. Abnormal regulation of DDB2 gene expression in xeroderma pigmentosum group E strains. Oncogene. 2001 Oct 25;20(48).7041-50.
147. Murai M, Enokido Y, Inamura N, Yoshino M, Nakatsu Y, van der Horst GT, Hoeijmakers JH, Tanaka K, Hatanaka H. Early postnatal ataxia and abnormal cerebellar development in mice lacking Xeroderma pigmentosum Group A and Cockayne syndrome Group B DNA repair genes. Proc Natl Acad Sci U S A. 2001 Nov 6;98(23).13379-84. Epub 2001 Oct 30.
148. Nag A, Bondar T, Shiv S, Raychaudhuri P. The xeroderma pigmentosum group E gene product DDB2 is a specific target of cullin 4A in mammalian cells. Mol Cell Biol. 2001 Oct;21(20).6738-47.
149. Gozukara EM, Khan SG, Metin A, Emmert S, Busch DB, Shahlavi T, Coleman DM, Miller M, Chinsomboon N, Stefanini M, Kraemer KH. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy. molecular genetic evidence for a common ancestor. J Invest Dermatol. 2001 Aug;117(2).197-204.
150. Rouberol F, Burillon C, Kodjikian L, Simon P, Bouvier R, Denis P. [Conjunctival epithelial carcinoma in a 9-year-old child with xeroderma pigmentosum. Case report]. J Fr Ophtalmol. 2001 Jun;24(6).639-42. French.
151. Bernerd F, Asselineau D, Vioux C, Chevallier-Lagente O, Bouadjar B, Sarasin A, Magnaldo T. Clues to epidermal cancer proneness revealed by reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro. Proc Natl Acad Sci U S A. 2001 Jul 3;98(14).7817-22.
152. Fazaa B, Zghal M, Bailly C, Zeglaoui F, Goucha S, Mokhtar I, Kharfi M, Ezzine N, Kamoun MR. [Melanoma in xeroderma pigmentosum. 12 cases]. Ann Dermatol Venereol. 2001 Apr;128(4).503-6. French.
153. Miyauchi-Hashimoto H, Kuwamoto K, Urade Y, Tanaka K, Horio T. Carcinogen-induced inflammation and immunosuppression are enhanced in xeroderma pigmentosum group A model mice associated with hyperproduction of prostaglandin E2. J Immunol. 2001 May 1;166(9).5782-91.
154. Spatz A, Giglia-Mari G, Benhamou S, Sarasin A. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum. Cancer Res. 2001 Mar 15;61(6).2480-6.
155. Ide F, Oda H, Nakatsuru Y, Kusama K, Sakashita H, Tanaka K, Ishikawa T. Xeroderma pigmentosum group A gene action as a protection factor against 4-nitroquinoline 1-oxide-induced tongue carcinogenesis. Carcinogenesis. 2001 Apr;22(4).567-72.
156. Araki M, Masutani C, Takemura M, Uchida A, Sugasawa K, Kondoh J, Ohkuma Y, Hanaoka F. Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J Biol Chem. 2001 Jun 1;276(22).18665-72. Epub 2001 Feb 27.
157. Dieng MT, Niang SO, Dangou JM, Ndiaye B. [Xeroderma pigmentosum. report of 6 cases in Dakar]. Bull Cancer. 2001 Feb;88(2).199-202. French.
158. Rosenberg E, Taher MM, Kuemmerle NB, Farnsworth J, Valerie K. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin. Cancer Res. 2001 Jan 15;61(2).764-70.
159. Ahmed H, Hassan RY, Pindiga UH. Xeroderma pigmentosum in three consecutive siblings of a Nigerian family. observations on oculocutaneous manifestations in black African children. Br J Ophthalmol. 2001 Jan;85(1).110-1.
160. Bullock SK, Kaufmann WK, Cordeiro-Stone M. Enhanced S phase delay and inhibition of replication of an undamaged shuttle vector in UVC-irradiated xeroderma pigmentosum variant. Carcinogenesis. 2001 Feb;22(2).233-41.
161. Kannouche P, Broughton BC, Volker M, Hanaoka F, Mullenders LH, Lehmann AR. Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. Genes Dev. 2001 Jan 15;15(2).158-72.
162. Lehmann AR. The xeroderma pigmentosum group D (XPD) gene. one gene, two functions, three diseases. Genes Dev. 2001 Jan 1;15(1).15-23. Review.
163. Itoh T, Linn S, Kamide R, Tokushige H, Katori N, Hosaka Y, Yamaizumi M. Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation. J Invest Dermatol. 2000 Dec;115(6).981-5.
164. Slor H, Batko S, Khan SG, Sobe T, Emmert S, Khadavi A, Frumkin A, Busch DB, Albert RB, Kraemer KH. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene. sun protection prolongs life. J Invest Dermatol. 2000 Dec;115(6).974-80.
165. Soufir N, Daya-Grosjean L, de La Salmonière P, Moles JP, Dubertret L, Sarasin A, Basset-Seguin N. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients. J Natl Cancer Inst. 2000 Nov 15;92(22).1841-7.
166. Yuasa M, Masutani C, Eki T, Hanaoka F. Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene. Oncogene. 2000 Sep 28;19(41).4721-8.
167. Douziech M, Coin F, Chipoulet JM, Arai Y, Ohkuma Y, Egly JM, Coulombe B. Mechanism of promoter melting by the xeroderma pigmentosum complementation group B helicase of transcription factor IIH revealed by protein-DNA photo-cross-linking. Mol Cell Biol. 2000 Nov;20(21).8168-77.
168. Khan SG, Metter EJ, Tarone RE, Bohr VA, Grossman L, Hedayati M, Bale SJ, Emmert S, Kraemer KH. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis. 2000 Oct;21(10).1821-5.
169. Petit-Frère C, Capulas E, Lowe JE, Koulu L, Marttila RJ, Jaspers NG, Clingen PH, Green MH, Arlett CF. Ultraviolet-B-induced apoptosis and cytokine release in xeroderma pigmentosum keratinocytes. J Invest Dermatol. 2000 Oct;115(4).687-93.
170. Tang JY, Hwang BJ, Ford JM, Hanawalt PC, Chu G. Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis. Mol Cell. 2000 Apr;5(4).737-44.
171. Yamada A, Masutani C, Iwai S, Hanaoka F. Complementation of defective translesion synthesis and UV light sensitivity in xeroderma pigmentosum variant cells by human and mouse DNA polymerase eta. Nucleic Acids Res. 2000 Jul 1;28(13).2473-80.
172. Limoli CL, Giedzinski E, Morgan WF, Cleaver JE. Polymerase eta deficiency in the xeroderma pigmentosum variant uncovers an overlap between the S phase checkpoint and double-strand break repair. Proc Natl Acad Sci U S A. 2000 Jul 5;97(14).7939-46.
173. Moussala M, Behar-Cohen F, D'hermies F, Bisseck AC, Renard G. [Xeroderma pigmentosum and its ocular manifestations. The first case in Cameroon]. J Fr Ophtalmol. 2000 Apr;23(4).369-74. French.
174. Itoh T, Linn S, Ono T, Yamaizumi M. Reinvestigation of the classification of five cell strains of xeroderma pigmentosum group E with reclassification of three of them. J Invest Dermatol. 2000 May;114(5).1022-9.
175. Colella S, Nardo T, Botta E, Lehmann AR, Stefanini M. Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis-cacchione variant of xeroderma pigmentosum. Hum Mol Genet. 2000 May 1;9(8).1171-5.
176. Chavanne F, Broughton BC, Pietra D, Nardo T, Browitt A, Lehmann AR, Stefanini M. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res. 2000 Apr 1;60(7).1974-82.
177. Otoshi E, Yagi T, Mori T, Matsunaga T, Nikaido O, Kim ST, Hitomi K, Ikenaga M, Todo T. Respective roles of cyclobutane pyrimidine dimers, (6-4)photoproducts, and minor photoproducts in ultraviolet mutagenesis of repair-deficient xeroderma pigmentosum A cells. Cancer Res. 2000 Mar 15;60(6).1729-35.
178. Yokoi M, Masutani C, Maekawa T, Sugasawa K, Ohkuma Y, Hanaoka F. The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor IIH to damaged DNA. J Biol Chem. 2000 Mar 31;275(13).9870-5.
179. Emmert S, Kobayashi N, Khan SG, Kraemer KH. The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts. Proc Natl Acad Sci U S A. 2000 Feb 29;97(5).2151-6.
180. D'Errico M, Calcagnile A, Canzona F, Didona B, Posteraro P, Cavalieri R, Corona R, Vorechovsky I, Nardo T, Stefanini M, Dogliotti E. UV mutation signature in tumor suppressor genes involved in skin carcinogenesis in xeroderma pigmentosum patients. Oncogene. 2000 Jan 20;19(3).463-7.
181. Kuwamoto K, Miyauchi-Hashimoto H, Tanaka K, Eguchi N, Inui T, Urade Y, Horio T. Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice. J Invest Dermatol. 2000 Feb;114(2).241-6.
182. Balajee AS, Dianova I, Bohr VA. Oxidative damage-induced PCNA complex formation is efficient in xeroderma pigmentosum group A but reduced in Cockayne syndrome group B cells. Nucleic Acids Res. 1999 Nov 15;27(22).4476-82.
183. Itoh T, Mori T, Ohkubo H, Yamaizumi M. A newly identified patient with clinical xeroderma pigmentosum phenotype has a non-sense mutation in the DDB2 gene and incomplete repair in (6-4) photoproducts. J Invest Dermatol. 1999 Aug;113(2).251-7.
184. Lipinski LJ, Hoehr N, Mazur SJ, Dianov GL, Sentürker S, Dizdaroglu M, Bohr VA. Repair of oxidative DNA base lesions induced by fluorescent light is defective in xeroderma pigmentosum group A cells. Nucleic Acids Res. 1999 Aug 1;27(15).3153-8.
185. Johnson RE, Kondratick CM, Prakash S, Prakash L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science. 1999 Jul 9;285(5425).263-5.
186. Miyauchi-Hashimoto H, Okamoto H, Tanaka K, Horio T. Ultraviolet radiation-induced suppression of natural killer cell activity is enhanced in xeroderma pigmentosum group A (XPA) model mice. J Invest Dermatol. 1999 Jun;112(6).965-70.
187. Masutani C, Araki M, Yamada A, Kusumoto R, Nogimori T, Maekawa T, Iwai S, Hanaoka F. Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity. EMBO J. 1999 Jun 15;18(12).3491-501.
188. Kurita M, Matsumoto M, Tsuji S, Kawakami M, Suzuki Y, Hayashi H, Toyoshima K, Seya T. Antibody-independent classical complement pathway activation and homologous C3 deposition in xeroderma pigmentosum cell lines. Clin Exp Immunol. 1999 Jun;116(3).547-53.
189. Riou L, Zeng L, Chevallier-Lagente O, Stary A, Nikaido O, Taïeb A, Weeda G, Mezzina M, Sarasin A. The relative expression of mutated XPB genes results in xeroderma pigmentosum/Cockayne's syndrome or trichothiodystrophy cellular phenotypes. Hum Mol Genet. 1999 Jun;8(6).1125-33.
190. Bodak N, Queille S, Avril MF, Bouadjar B, Drougard C, Sarasin A, Daya-Grosjean L. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum. Proc Natl Acad Sci U S A. 1999 Apr 27;96(9).5117-22.
191. Reynaud E, Lomelí H, Vázquez M, Zurita M. The Drosophila melanogaster homologue of the Xeroderma pigmentosum D gene product is located in euchromatic regions and has a dynamic response to UV light-induced lesions in polytene chromosomes. Mol Biol Cell. 1999 Apr;10(4).1191-203.
192. Cleaver JE, Afzal V, Feeney L, McDowell M, Sadinski W, Volpe JP, Busch DB, Coleman DM, Ziffer DW, Yu Y, Nagasawa H, Little JB. Increased ultraviolet sensitivity and chromosomal instability related to P53 function in the xeroderma pigmentosum variant. Cancer Res. 1999 Mar 1;59(5).1102-8.
193. Coin F, Bergmann E, Tremeau-Bravard A, Egly JM. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH. EMBO J. 1999 Mar 1;18(5).1357-66.
194. Cheo DL, Burns DK, Meira LB, Houle JF, Friedberg EC. Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-/- mice. Cancer Res. 1999 Feb 15;59(4).771-5.
195. Harada YN, Shiomi N, Koike M, Ikawa M, Okabe M, Hirota S, Kitamura Y, Kitagawa M, Matsunaga T, Nikaido O, Shiomi T. Postnatal growth failure, short life span, and early onset of cellular senescence and subsequent immortalization in mice lacking the xeroderma pigmentosum group G gene. Mol Cell Biol. 1999 Mar;19(3).2366-72.
196. Cordonnier AM, Lehmann AR, Fuchs RP. Impaired translesion synthesis in xeroderma pigmentosum variant extracts. Mol Cell Biol. 1999 Mar;19(3).2206-11.
197. Hwang BJ, Ford JM, Hanawalt PC, Chu G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc Natl Acad Sci U S A. 1999 Jan 19;96(2).424-8.
198. Takeda N, Shibuya M, Maru Y. The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein. Proc Natl Acad Sci U S A. 1999 Jan 5;96(1).203-7.
199. Yagi T, Katsuya A, Koyano A, Takebe H. Sensitivity of group F xeroderma pigmentosum cells to UV and mitomycin C relative to levels of XPF and ERCC1 overexpression. Mutagenesis. 1998 Nov;13(6).595-9.
200. McGregor WG, Wei D, Maher VM, McCormick JJ. Abnormal, error-prone bypass of photoproducts by xeroderma pigmentosum variant cell extracts results in extreme strand bias for the kinds of mutations induced by UV light. Mol Cell Biol. 1999 Jan;19(1).147-54.
201. Fackel N, Dertinger H, Wolf GK. Induction of sister chromatid exchanges in fibroblasts from normal donors and from patients with xeroderma pigmentosum after combined treatment with ultraviolet radiation and modulated low frequency electric currents. Eur J Dermatol. 1998 Oct-Nov;8(7).483-7.
202. Tantin D. RNA polymerase II elongation complexes containing the Cockayne syndrome group B protein interact with a molecular complex containing the transcription factor IIH components xeroderma pigmentosum B and p62. J Biol Chem. 1998 Oct 23;273(43).27794-9.
203. Giglia G, Dumaz N, Drougard C, Avril MF, Daya-Grosjean L, Sarasin A. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res. 1998 Oct 1;58(19).4402-9.
204. Kobayashi T, Takeuchi S, Saijo M, Nakatsu Y, Morioka H, Otsuka E, Wakasugi M, Nikaido O, Tanaka K. Mutational analysis of a function of xeroderma pigmentosum group A (XPA) protein in strand-specific DNA repair. Nucleic Acids Res. 1998 Oct 15;26(20).4662-8.
205. Baxter BK, Smerdon MJ. Nucleosome unfolding during DNA repair in normal and xeroderma pigmentosum (group C) human cells. J Biol Chem. 1998 Jul 10;273(28).17517-24.
206. Hwang BJ, Toering S, Francke U, Chu G. p48 Activates a UV-damaged-DNA binding factor and is defective in xeroderma pigmentosum group E cells that lack binding activity. Mol Cell Biol. 1998 Jul;18(7).4391-9.
207. Rapić Otrin V, Kuraoka I, Nardo T, McLenigan M, Eker AP, Stefanini M, Levine AS, Wood RD. Relationship of the xeroderma pigmentosum group E DNA repair defect to the chromatin and DNA binding proteins UV-DDB and replication protein A. Mol Cell Biol. 1998 Jun;18(6).3182-90.
208. Matsumura Y, Nishigori C, Yagi T, Imamura S, Takebe H. Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms. Hum Mol Genet. 1998 Jun;7(6).969-74.
209. Williams C, Pontén F, Ahmadian A, Ren ZP, Ling G, Rollman O, Ljung A, Jaspers NG, Uhlén M, Lundeberg J, Pontén J. Clones of normal keratinocytes and a variety of simultaneously present epidermal neoplastic lesions contain a multitude of p53 gene mutations in a xeroderma pigmentosum patient. Cancer Res. 1998 Jun 1;58(11).2449-55.
210. Svoboda DL, Briley LP, Vos JM. Defective bypass replication of a leading strand cyclobutane thymine dimer in xeroderma pigmentosum variant cell extracts. Cancer Res. 1998 Jun 1;58(11).2445-8.
211. Sijbers AM, van Voorst Vader PC, Snoek JW, Raams A, Jaspers NG, Kleijer WJ. Homozygous R788W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease. J Invest Dermatol. 1998 May;110(5).832-6.
212. Yagi T, Matsumura Y, Sato M, Nishigori C, Mori T, Sijbers AM, Takebe H. Complete restoration of normal DNA repair characteristics in group F xeroderma pigmentosum cells by over-expression of transfected XPF cDNA. Carcinogenesis. 1998 Jan;19(1).55-60.
213. Winkler GS, Vermeulen W, Coin F, Egly JM, Hoeijmakers JH, Weeda G. Affinity purification of human DNA repair/transcription factor TFIIH using epitope-tagged xeroderma pigmentosum B protein. J Biol Chem. 1998 Jan 9;273(2).1092-8.
214. Zeng L, Quilliet X, Chevallier-Lagente O, Eveno E, Sarasin A, Mezzina M. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C. Gene Ther. 1997 Oct;4(10).1077-84.
215. de Boer J, Donker I, de Wit J, Hoeijmakers JH, Weeda G. Disruption of the mouse xeroderma pigmentosum group D DNA repair/basal transcription gene results in preimplantation lethality. Cancer Res. 1998 Jan 1;58(1).89-94.
216. Terleth C, van Laar T, Schouten R, van Steeg H, Hodemaekers H, Wormhoudt T, Cornelissen-Steijger PD, Abrahams PJ, van der Eb AJ. A lack of radiation-induced ornithine decarboxylase activity prevents enhanced reactivation of herpes simplex virus and is linked to non-cancer proneness in xeroderma pigmentosum patients. Cancer Res. 1997 Oct 1;57(19).4384-92.
217. Merk O, Speit G. Characterization of SV40-transformed xeroderma pigmentosum cell lines for their usability in HPRT mutation studies. Mutagenesis. 1997 Sep;12(5).391-5.
218. Dianov GL, Houle JF, Iyer N, Bohr VA, Friedberg EC. Reduced RNA polymerase II transcription in extracts of cockayne syndrome and xeroderma pigmentosum/Cockayne syndrome cells. Nucleic Acids Res. 1997 Sep 15;25(18).3636-42.
219. Reardon JT, Bessho T, Kung HC, Bolton PH, Sancar A. In vitro repair of oxidative DNA damage by human nucleotide excision repair system. possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc Natl Acad Sci U S A. 1997 Aug 19;94(17).9463-8.
220. Tu Y, Bates S, Pfeifer GP. Sequence-specific and domain-specific DNA repair in xeroderma pigmentosum and Cockayne syndrome cells. J Biol Chem. 1997 Aug 15;272(33).20747-55.
221. Taylor EM, Broughton BC, Botta E, Stefanini M, Sarasin A, Jaspers NG, Fawcett H, Harcourt SA, Arlett CF, Lehmann AR. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16).8658-63.
222. Kim N, Kage K, Matsuda F, Lefranc MP, Storb U. B lymphocytes of xeroderma pigmentosum or Cockayne syndrome patients with inherited defects in nucleotide excision repair are fully capable of somatic hypermutation of immunoglobulin genes. J Exp Med. 1997 Aug 4;186(3).413-9.
223. Lee SK, Yu SL, Garcia MX, Alexander H, Alexander S. Differential developmental expression of the rep B and rep D xeroderma pigmentosum related DNA helicase genes from Dictyostelium discoideum. Nucleic Acids Res. 1997 Jun 15;25(12).2365-74.
224. Nouspikel T, Lalle P, Leadon SA, Cooper PK, Clarkson SG. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G. implications for a second XPG function. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7).3116-21. Partial retraction in. Snyder SH. Proc Natl Acad Sci U S A. 2006 Dec 19;103(51).19606.
225. Feng S, Parrish DD, Lambert MW. A processive versus a distributive mechanism of action correlates with differences in ability of normal and xeroderma pigmentosum group A endonucleases to incise damaged nucleosomal DNA. Carcinogenesis. 1997 Feb;18(2).279-86.
226. Yagi T, Wood RD, Takebe H. A low content of ERCC1 and a 120 kDa protein is a frequent feature of group F xeroderma pigmentosum fibroblast cells. Mutagenesis. 1997 Jan;12(1).41-4.
227. Nichols AF, Ong P, Linn S. Mutations specific to the xeroderma pigmentosum group E Ddb- phenotype. J Biol Chem. 1996 Oct 4;271(40).24317-20.
228. Mehta C, Gupta CN, Krishnaswamy M. Malignant melanoma of conjunctiva with xeroderma pigmentosa--a case report. Indian J Ophthalmol. 1996 Sep;44(3).165-6.
229. Myrand SP, Topping RS, States JC. Stable transformation of xeroderma pigmentosum group A cells with an XPA minigene restores normal DNA repair and mutagenesis of UV-treated plasmids. Carcinogenesis. 1996 Sep;17(9).1909-17.
230. Park MS, Knauf JA, Pendergrass SH, Coulon CH, Strniste GF, Marrone BL, MacInnes MA. Ultraviolet-induced movement of the human DNA repair protein, Xeroderma pigmentosum type G, in the nucleus. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16).8368-73.
231. Hwang JR, Moncollin V, Vermeulen W, Seroz T, van Vuuren H, Hoeijmakers JH, Egly JM. A 3' --> 5' XPB helicase defect in repair/transcription factor TFIIH of xeroderma pigmentosum group B affects both DNA repair and transcription. J Biol Chem. 1996 Jul 5;271(27).15898-904.
232. Hamel BC, Raams A, Schuitema-Dijkstra AR, Simons P, van der Burgt I, Jaspers NG, Kleijer WJ. Xeroderma pigmentosum--Cockayne syndrome complex. a further case. J Med Genet. 1996 Jul;33(7).607-10.
233. Alexander H, Lee SK, Yu SL, Alexander S. repE--the Dictyostelium homolog of the human xeroderma pigmentosum group E gene is developmentally regulated and contains a leucine zipper motif. Nucleic Acids Res. 1996 Jun 15;24(12).2295-301.
234. Ayaki H, Hara R, Ikenaga M. Recovery from ultraviolet tight-induced depression of ribosomal RNA synthesis in normal human, xeroderma pigmentosum and Cockayne syndrome cells. J Radiat Res. 1996 Jun;37(2).107-16.
235. Abrahams PJ, Houweling A, Cornelissen-Steijger DM, Arwert F, Menko FH, Pinedo HM, Terleth C, van der Eb AJ. Inheritance of abnormal expression of SOS-like response in xeroderma pigmentosum and hereditary cancer-prone syndromes. Cancer Res. 1996 Jun 1;56(11).2621-5.
236. Kazantsev A, Mu D, Nichols AF, Zhao X, Linn S, Sancar A. Functional complementation of xeroderma pigmentosum complementation group E by replication protein A in an in vitro system. Proc Natl Acad Sci U S A. 1996 May 14;93(10).5014-8.
237. Wagner SD, Elvin JG, Norris P, McGregor JM, Neuberger MS. Somatic hypermutation of Ig genes in patients with xeroderma pigmentosum (XP-D). Int Immunol. 1996 May;8(5).701-5.
238. Raha M, Wang G, Seidman MM, Glazer PM. Mutagenesis by third-strand-directed psoralen adducts in repair-deficient human cells. high frequency and altered spectrum in a xeroderma pigmentosum variant. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7).2941-6.
239. Tada S, Yanagisawa J, Sonoyama T, Miyajima A, Seki M, Ui M, Enomoto T. Characterization of the properties of a human homologue of Escherichia coli RecQ from xeroderma pigmentosum group C and from HeLa cells. Cell Struct Funct. 1996 Apr;21(2).123-32.
240. Driggers WJ, Grishko VI, LeDoux SP, Wilson GL. Defective repair of oxidative damage in the mitochondrial DNA of a xeroderma pigmentosum group A cell line. Cancer Res. 1996 Mar 15;56(6).1262-6.
241. Takayama K, Salazar EP, Lehmann A, Stefanini M, Thompson LH, Weber CA. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D. Cancer Res. 1995 Dec 1;55(23).5656-63.
242. Tateishi S, Mori S, Sugano T, Hori N, Ohtsuka E, Yamaizumi M. Separation of protein factors that correct the defects in the seven complementation groups of xeroderma pigmentosum cells. J Biochem. 1995 Oct;118(4).819-24.
243. Eveno E, Bourre F, Quilliet X, Chevallier-Lagente O, Roza L, Eker AP, Kleijer WJ, Nikaido O, Stefanini M, Hoeijmakers JH, et al. Different removal of ultraviolet photoproducts in genetically related xeroderma pigmentosum and trichothiodystrophy diseases. Cancer Res. 1995 Oct 1;55(19).4325-32.
244. Lee SH, Kim DK, Drissi R. Human xeroderma pigmentosum group A protein interacts with human replication protein A and inhibits DNA replication. J Biol Chem. 1995 Sep 15;270(37).21800-5.
245. Guzder SN, Sung P, Prakash S, Prakash L. Lethality in yeast of trichothiodystrophy (TTD) mutations in the human xeroderma pigmentosum group D gene. Implications for transcriptional defect in TTD. J Biol Chem. 1995 Jul 28;270(30).17660-3.
246. Itoh T, Fujiwara Y, Ono T, Yamaizumi M. UVs syndrome, a new general category of photosensitive disorder with defective DNA repair, is distinct from xeroderma pigmentosum variant and rodent complementation group I. Am J Hum Genet. 1995 Jun;56(6).1267-76.
247. van Hoffen A, Venema J, Meschini R, van Zeeland AA, Mullenders LH. Transcription-coupled repair removes both cyclobutane pyrimidine dimers and 6-4 photoproducts with equal efficiency and in a sequential way from transcribed DNA in xeroderma pigmentosum group C fibroblasts. EMBO J. 1995 Jan 16;14(2).360-7.
248. Broughton BC, Thompson AF, Harcourt SA, Vermeulen W, Hoeijmakers JH, Botta E, Stefanini M, King MD, Weber CA, Cole J, et al. Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome. Am J Hum Genet. 1995 Jan;56(1).167-74. Review.
249. Yamashiro S, Nagahiro S, Mimata C, Kuratsu J, Ushio Y. Malignant trigeminal schwannoma associated with xeroderma pigmentosum--case report. Neurol Med Chir (Tokyo). 1994 Dec;34(12).817-20. Review.
250. Ma L, Siemssen ED, Noteborn HM, van der Eb AJ. The xeroderma pigmentosum group B protein ERCC3 produced in the baculovirus system exhibits DNA helicase activity. Nucleic Acids Res. 1994 Oct 11;22(20).4095-102.
251. Shivji MK, Eker AP, Wood RD. DNA repair defect in xeroderma pigmentosum group C and complementing factor from HeLa cells. J Biol Chem. 1994 Sep 9;269(36).22749-57.
252. Fujikawa K, Ayaki H, Ishizaki K, Takatera H, Matsuo S, Iizuka H, Koizumi H, Ikenaga M. Assignment of six patients with xeroderma pigmentosum in Hokkaido area to a variant form. J Radiat Res. 1994 Sep;35(3).168-78.
253. Habraken Y, Sung P, Prakash L, Prakash S. Human xeroderma pigmentosum group G gene encodes a DNA endonuclease. Nucleic Acids Res. 1994 Aug 25;22(16).3312-6.
254. Gözükara EM, Parris CN, Weber CA, Salazar EP, Seidman MM, Watkins JF, Prakash L, Kraemer KH. The human DNA repair gene, ERCC2 (XPD), corrects ultraviolet hypersensitivity and ultraviolet hypermutability of a shuttle vector replicated in xeroderma pigmentosum group D cells. Cancer Res. 1994 Jul 15;54(14).3837-44.
255. Keeney S, Eker AP, Brody T, Vermeulen W, Bootsma D, Hoeijmakers JH, Linn S. Correction of the DNA repair defect in xeroderma pigmentosum group E by injection of a DNA damage-binding protein. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9).4053-6.
256. Masutani C, Sugasawa K, Yanagisawa J, Sonoyama T, Ui M, Enomoto T, Takio K, Tanaka K, van der Spek PJ, Bootsma D, et al. Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J. 1994 Apr 15;13(8).1831-43.
257. Goyal JL, Rao VA, Srinivasan R, Agrawal K. Oculocutaneous manifestations in xeroderma pigmentosa. Br J Ophthalmol. 1994 Apr;78(4).295-7. Review.
258. van Vuuren AJ, Vermeulen W, Ma L, Weeda G, Appeldoorn E, Jaspers NG, van der Eb AJ, Bootsma D, Hoeijmakers JH, Humbert S, et al. Correction of xeroderma pigmentosum repair defect by basal transcription factor BTF2 (TFIIH). EMBO J. 1994 Apr 1;13(7).1645-53.
259. Milo Y, Deutsch AA, Zahavi S, Ingber A, Reiss R. Xeroderma pigmentosum with recurrent infiltrating ductal carcinoma of breast. Postgrad Med J. 1994 Mar;70(821).240-1.
260. Henning KA, Peterson C, Legerski R, Friedberg EC. Cloning the Drosophila homolog of the xeroderma pigmentosum complementation group C gene reveals homology between the predicted human and Drosophila polypeptides and that encoded by the yeast RAD4 gene. Nucleic Acids Res. 1994 Feb 11;22(3).257-61.
261. Vermeulen W, Scott RJ, Rodgers S, Müller HJ, Cole J, Arlett CF, Kleijer WJ, Bootsma D, Hoeijmakers JH, Weeda G. Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3. Am J Hum Genet. 1994 Feb;54(2).191-200.
262. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22).10529-33.
263. Evans MK, Taffe BG, Harris CC, Bohr VA. DNA strand bias in the repair of the p53 gene in normal human and xeroderma pigmentosum group C fibroblasts. Cancer Res. 1993 Nov 15;53(22).5377-81.
264. Nishigori C, Zghal M, Yagi T, Imamura S, Komoun MR, Takebe H. High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia. Am J Hum Genet. 1993 Nov;53(5).1001-6.
265. Keeney S, Chang GJ, Linn S. Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E. J Biol Chem. 1993 Oct 5;268(28).21293-300.
266. van Vuuren AJ, Appeldoorn E, Odijk H, Yasui A, Jaspers NG, Bootsma D, Hoeijmakers JH. Evidence for a repair enzyme complex involving ERCC1 and complementing activities of ERCC4, ERCC11 and xeroderma pigmentosum group F. EMBO J. 1993 Sep;12(9).3693-701.
267. Biggerstaff M, Szymkowski DE, Wood RD. Co-correction of the ERCC1, ERCC4 and xeroderma pigmentosum group F DNA repair defects in vitro. EMBO J. 1993 Sep;12(9).3685-92.
268. Vivian AJ, Ellison DW, McGill JI. Ocular melanomas in xeroderma pigmentosum. Br J Ophthalmol. 1993 Sep;77(9).597-8.
269. Gaspari AA, Fleisher TA, Kraemer KH. Impaired interferon production and natural killer cell activation in patients with the skin cancer-prone disorder, xeroderma pigmentosum. J Clin Invest. 1993 Sep;92(3).1135-42.
270. Takao M, Abramic M, Moos M Jr, Otrin VR, Wootton JC, McLenigan M, Levine AS, Protic M. A 127 kDa component of a UV-damaged DNA-binding complex, which is defective in some xeroderma pigmentosum group E patients, is homologous to a slime mold protein. Nucleic Acids Res. 1993 Aug 25;21(17).4111-8.
271. Satoh MS, Jones CJ, Wood RD, Lindahl T. DNA excision-repair defect of xeroderma pigmentosum prevents removal of a class of oxygen free radical-induced base lesions. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13).6335-9.
272. Wang YC, Maher VM, Mitchell DL, McCormick JJ. Evidence from mutation spectra that the UV hypermutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a template containing photoproducts. Mol Cell Biol. 1993 Jul;13(7).4276-83.
273. Sato M, Nishigori C, Zghal M, Yagi T, Takebe H. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients. Cancer Res. 1993 Jul 1;53(13).2944-6.
274. Vermeulen W, Jaeken J, Jaspers NG, Bootsma D, Hoeijmakers JH. Xeroderma pigmentosum complementation group G associated with Cockayne syndrome. Am J Hum Genet. 1993 Jul;53(1).185-92.
275. Fujiwara Y, Nakamura M, Yokoo S. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II). DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells. Br J Cancer. 1993 Jun;67(6).1285-92.
276. Berth-Jones J, Cole J, Lehmann AR, Arlett CF, Graham-Brown RA. Xeroderma pigmentosum variant. 5 years of tumour suppression by etretinate. J R Soc Med. 1993 Jun;86(6).355-6.
277. Masutani C, Sugasawa K, Asahina H, Tanaka K, Hanaoka F. Cell-free repair of UV-damaged simian virus 40 chromosomes in human cell extracts. II. Defective DNA repair synthesis by xeroderma pigmentosum cell extracts. J Biol Chem. 1993 Apr 25;268(12).9105-9.
278. Daya-Grosjean L, Robert C, Drougard C, Suarez H, Sarasin A. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients. Cancer Res. 1993 Apr 1;53(7).1625-9.
279. Evans MK, Robbins JH, Ganges MB, Tarone RE, Nairn RS, Bohr VA. Gene-specific DNA repair in xeroderma pigmentosum complementation groups A, C, D, and F. Relation to cellular survival and clinical features. J Biol Chem. 1993 Mar 5;268(7).4839-47.
280. Lommel L, Hanawalt PC. Increased UV resistance of a xeroderma pigmentosum revertant cell line is correlated with selective repair of the transcribed strand of an expressed gene. Mol Cell Biol. 1993 Feb;13(2).970-6.
281. Misra RR, Vos JM. Defective replication of psoralen adducts detected at the gene-specific level in xeroderma pigmentosum variant cells. Mol Cell Biol. 1993 Feb;13(2).1002-12.
282. Park E, Guzder SN, Koken MH, Jaspers-Dekker I, Weeda G, Hoeijmakers JH, Prakash S, Prakash L. RAD25 (SSL2), the yeast homolog of the human xeroderma pigmentosum group B DNA repair gene, is essential for viability. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23).11416-20.
283. Treiber DK, Chen Z, Essigmann JM. An ultraviolet light-damaged DNA recognition protein absent in xeroderma pigmentosum group E cells binds selectively to pyrimidine (6-4) pyrimidone photoproducts. Nucleic Acids Res. 1992 Nov 11;20(21).5805-10.
284. Koken MH, Vreeken C, Bol SA, Cheng NC, Jaspers-Dekker I, Hoeijmakers JH, Eeken JC, Weeda G, Pastink A. Cloning and characterization of the Drosophila homolog of the xeroderma pigmentosum complementation-group B correcting gene, ERCC3. Nucleic Acids Res. 1992 Nov 11;20(21).5541-8.
285. Levy DD, Groopman JD, Lim SE, Seidman MM, Kraemer KH. Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res. 1992 Oct 15;52(20).5668-73.
286. Miyamoto I, Miura N, Niwa H, Miyazaki J, Tanaka K. Mutational analysis of the structure and function of the xeroderma pigmentosum group A complementing protein. Identification of essential domains for nuclear localization and DNA excision repair. J Biol Chem. 1992 Jun 15;267(17).12182-7.
287. Mariani E, Facchini A, Honorati MC, Lalli E, Berardesca E, Ghetti P, Marinoni S, Nuzzo F, Astaldi Ricotti GC, Stefanini M. Immune defects in families and patients with xeroderma pigmentosum and trichothiodystrophy. Clin Exp Immunol. 1992 Jun;88(3).376-82.
288. Greenhaw GA, Hebert A, Duke-Woodside ME, Butler IJ, Hecht JT, Cleaver JE, Thomas GH, Horton WA. Xeroderma pigmentosum and Cockayne syndrome. overlapping clinical and biochemical phenotypes. Am J Hum Genet. 1992 Apr;50(4).677-89.
289. Jones CJ, Cleaver JE, Wood RD. Repair of damaged DNA by extracts from a xeroderma pigmentosum complementation group A revertant and expression of a protein absent in its parental cell line. Nucleic Acids Res. 1992 Mar 11;20(5).991-5.
290. Yanagisawa J, Seki M, Ui M, Enomoto T. Alteration of a DNA-dependent ATPase activity in xeroderma pigmentosum complementation group C cells. J Biol Chem. 1992 Feb 25;267(6).3585-8.
291. Paridaens AD, McCartney AC, Hungerford JL. Premalignant melanosis of the conjunctiva and the cornea in xeroderma pigmentosum. Br J Ophthalmol. 1992 Feb;76(2).120-2.
292. Flejter WL, McDaniel LD, Johns D, Friedberg EC, Schultz RA. Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer. involvement of the human ERCC2 DNA repair gene. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1).261-5.
293. Robins P, Jones CJ, Biggerstaff M, Lindahl T, Wood RD. Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA. EMBO J. 1991 Dec;10(12).3913-21.
294. Weeda G, Ma LB, van Ham RC, van der Eb AJ, Hoeijmakers JH. Structure and expression of the human XPBC/ERCC-3 gene involved in DNA repair disorders xeroderma pigmentosum and Cockayne's syndrome. Nucleic Acids Res. 1991 Nov 25;19(22).6301-8.
295. Miura N, Miyamoto I, Asahina H, Satokata I, Tanaka K, Okada Y. Identification and characterization of xpac protein, the gene product of the human XPAC (xeroderma pigmentosum group A complementing) gene. J Biol Chem. 1991 Oct 15;266(29).19786-9.
296. Sugano T, Uchida T, Yamaizumi M. Identification of a specific protein factor defective in group A xeroderma pigmentosum cells. J Biochem. 1991 Oct;110(4).667-74.
297. Wang YC, Maher VM, McCormick JJ. Xeroderma pigmentosum variant cells are less likely than normal cells to incorporate dAMP opposite photoproducts during replication of UV-irradiated plasmids. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17).7810-4.
298. Venema J, van Hoffen A, Karcagi V, Natarajan AT, van Zeeland AA, Mullenders LH. Xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes. Mol Cell Biol. 1991 Aug;11(8).4128-34.
299. Thielmann HW, Popanda O, Edler L, Jung EG. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany. Cancer Res. 1991 Jul 1;51(13).3456-70.
300. Yagi T, Tatsumi-Miyajima J, Sato M, Kraemer KH, Takebe H. Analysis of point mutations in an ultraviolet-irradiated shuttle vector plasmid propagated in cells from Japanese xeroderma pigmentosum patients in complementation groups A and F. Cancer Res. 1991 Jun 15;51(12).3177-82.
301. Wang Y, Kobayashi K, Chang HR, Zeng Y, Ishizaki K, Dai H, Kuan YZ, Ikenaga M. Assignment of a Chinese xeroderma pigmentosum patient from Taiwan to complementation group C. J Radiat Res. 1991 Jun;32(2).181-90.
302. Seetharam S, Seidman MM. Modulation of an ultraviolet mutational hotspot in a shuttle vector Xeroderma cells. Nucleic Acids Res. 1991 Apr 11;19(7).1601-4.
303. Satokata I, Tanaka K, Miura N, Miyamoto I, Satoh Y, Kondo S, Okada Y. Characterization of a splicing mutation in group A xeroderma pigmentosum. Proc Natl Acad Sci U S A. 1990 Dec;87(24).9908-12.
304. Rinaldy A, Bellew T, Egli E, Lloyd RS. Increased UV resistance in xeroderma pigmentosum group A cells after transformation with a human genomic DNA clone. Proc Natl Acad Sci U S A. 1990 Sep;87(17).6818-22.
305. Boyer JC, Kaufmann WK, Brylawski BP, Cordeiro-Stone M. Defective postreplication repair in xeroderma pigmentosum variant fibroblasts. Cancer Res. 1990 May 1;50(9).2593-8.
306. Dubey AK, Nagar M, Gupta A, Sahu D, Mishra S. Xeroderma pigmentosum (case report). Indian J Ophthalmol. 1990 Apr-Jun;38(2).94-6.
307. Roza L, Vermeulen W, Bergen Henegouwen JB, Eker AP, Jaspers NG, Lohman PH, Hoeijmakers JH. Effects of microinjected photoreactivating enzyme on thymine dimer removal and DNA repair synthesis in normal human and xeroderma pigmentosum fibroblasts. Cancer Res. 1990 Mar 15;50(6).1905-10.
308. Venema J, van Hoffen A, Natarajan AT, van Zeeland AA, Mullenders LH. The residual repair capacity of xeroderma pigmentosum complementation group C fibroblasts is highly specific for transcriptionally active DNA. Nucleic Acids Res. 1990 Feb 11;18(3).443-8.
309. Hansson J, Grossman L, Lindahl T, Wood RD. Complementation of the xeroderma pigmentosum DNA repair synthesis defect with Escherichia coli UvrABC proteins in a cell-free system. Nucleic Acids Res. 1990 Jan 11;18(1).35-40.
310. Nuzzo F, Zei G, Stefanini M, Colognola R, Santachiara AS, Lagomarsini P, Marinoni S, Salvaneschi L. Search for consanguinity within and among families of patients with trichothiodystrophy associated with xeroderma pigmentosum. J Med Genet. 1990 Jan;27(1).21-5.
311. Parshad R, Sanford KK, Kraemer KH, Jones GM, Tarone RE. Carrier detection in xeroderma pigmentosum. J Clin Invest. 1990 Jan;85(1).135-8.
312. Kaur GP, Athwal RS. Complementation of a DNA repair defect in xeroderma pigmentosum cells by transfer of human chromosome 9. Proc Natl Acad Sci U S A. 1989 Nov;86(22).8872-6.
313. Patterson M, Chu G. Evidence that xeroderma pigmentosum cells from complementation group E are deficient in a homolog of yeast photolyase. Mol Cell Biol. 1989 Nov;9(11).5105-12.
314. Arrand JE, Bone NM, Johnson RT. Molecular cloning and characterization of a mammalian excision repair gene that partially restores UV resistance to xeroderma pigmentosum complementation group D cells. Proc Natl Acad Sci U S A. 1989 Sep;86(18).6997-7001.
315. Tanaka K, Satokata I, Ogita Z, Uchida T, Okada Y. Molecular cloning of a mouse DNA repair gene that complements the defect of group-A xeroderma pigmentosum. Proc Natl Acad Sci U S A. 1989 Jul;86(14).5512-6.
316. Kondo S, Satoh Y, Kuroki T. Reduced levels of UV-induced unscheduled DNA synthesis in epidermal keratinocytes of patients with xeroderma pigmentosum and correlation with development of skin neoplasms. Cancer Res. 1989 Apr 15;49(8).1927-30.
317. Saxon PJ, Schultz RA, Stanbridge EJ, Friedberg EC. Human chromosome 15 confers partial complementation of phenotypes to xeroderma pigmentosum group F cells. Am J Hum Genet. 1989 Apr;44(4).474-85.
318. Keijzer W, Mulder MP, Langeveld JC, Smit EM, Bos JL, Bootsma D, Hoeijmakers JH. Establishment and characterization of a melanoma cell line from a xeroderma pigmentosum patient. activation of N-ras at a potential pyrimidine dimer site. Cancer Res. 1989 Mar 1;49(5).1229-35.
319. Suarez HG, Daya-Grosjean L, Schlaifer D, Nardeux P, Renault G, Bos JL, Sarasin A. Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum. Cancer Res. 1989 Mar 1;49(5).1223-8.
320. Abrahams PJ, van der Kleij AA, Schouten R, van der Eb AJ. Absence of induction of enhanced reactivation of herpes simplex virus in cells from xeroderma pigmentosum patients without skin cancer. Cancer Res. 1988 Nov 1;48(21).6054-7.
321. Pippard EC, Hall AJ, Barker DJ, Bridges BA. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res. 1988 May 15;48(10).2929-32.
322. Crawford D, Zbinden I, Moret R, Cerutti P. Antioxidant enzymes in xeroderma pigmentosum fibroblasts. Cancer Res. 1988 Apr 15;48(8).2132-4.
323. Seguin LR, Tarone RE, Liao KH, Robbins JH. Ultraviolet light-induced chromosomal aberrations in cultured cells from Cockayne syndrome and complementation group C xeroderma pigmentosum patients. lack of correlation with cancer susceptibility. Am J Hum Genet. 1988 Mar;42(3).468-75.
324. Kantor GJ, Elking CF. Biological significance of domain-oriented DNA repair in xeroderma pigmentosum cells. Cancer Res. 1988 Feb 15;48(4).844-9.
325. Sono A, Sakaguchi K. Inhibition of protein synthesis does not antagonize induction of UV-induced sister-chromatid exchange in xeroderma pigmentosum cells. Cell Struct Funct. 1988 Feb;13(1).39-43.
326. Seetharam S, Protić-Sabljić M, Seidman MM, Kraemer KH. Abnormal ultraviolet mutagenic spectrum in plasmid DNA replicated in cultured fibroblasts from a patient with the skin cancer-prone disease, xeroderma pigmentosum. J Clin Invest. 1987 Dec;80(6).1613-7.
327. Teitz T, Naiman T, Avissar SS, Bar S, Okayama H, Canaani D. Complementation of the UV-sensitive phenotype of a xeroderma pigmentosum human cell line by transfection with a cDNA clone library. Proc Natl Acad Sci U S A. 1987 Dec;84(24).8801-4.
328. Arrand JE, Squires S, Bone NM, Johnson RT. Restoration of u.v.-induced excision repair in Xeroderma D cells transfected with the denV gene of bacteriophage T4. EMBO J. 1987 Oct;6(10).3125-31.
329. Cleaver JE, Cortés F, Lutze LH, Morgan WF, Player AN, Mitchell DL. Unique DNA repair properties of a xeroderma pigmentosum revertant. Mol Cell Biol. 1987 Sep;7(9).3353-7.
330. Valerie K, Green AP, de Riel JK, Henderson EE. Transient and stable complementation of ultraviolet repair in xeroderma pigmentosum cells by the denV gene of bacteriophage T4. Cancer Res. 1987 Jun 1;47(11).2967-71.
331. Schultz RA, Saxon PJ, Glover TW, Friedberg EC. Microcell-mediated transfer of a single human chromosome complements xeroderma pigmentosum group A fibroblasts. Proc Natl Acad Sci U S A. 1987 Jun;84(12).4176-9.
332. Cleaver JE. Relative importance of incision and polymerase activities in determining the distribution of damaged sites that are mended in xeroderma pigmentosum group C cells. Cancer Res. 1987 May 1;47(9).2393-6.
333. Bredberg A, Kraemer KH, Seidman MM. Restricted ultraviolet mutational spectrum in a shuttle vector propagated in xeroderma pigmentosum cells. Proc Natl Acad Sci U S A. 1986 Nov;83(21).8273-7.
334. Cleaver JE. DNA repair in human xeroderma pigmentosum group C cells involves a different distribution of damaged sites in confluent and growing cells. Nucleic Acids Res. 1986 Oct 24;14(20).8155-65.
335. Karentz D, Cleaver JE. Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells. Mol Cell Biol. 1986 Oct;6(10).3428-32.
336. Ida K. DNA repair characteristics of a hybrid cell clone between xeroderma pigmentosum and Potorous tridactilis. J Radiat Res. 1986 Sep;27(3).300-9.
337. Yamaizumi M, Sugano T, Asahina H, Okada Y, Uchida T. Microinjection of partially purified protein factor restores DNA damage specifically in group A of xeroderma pigmentosum cells. Proc Natl Acad Sci U S A. 1986 Mar;83(5).1476-9.
338. Imray FP, Hockey A, Relf W, Ramsay RG, Kidson C. Sensitivity to ultraviolet radiation in a dominantly inherited form of xeroderma pigmentosum. J Med Genet. 1986 Feb;23(1).72-8.
339. McCormick JJ, Kateley-Kohler S, Watanabe M, Maher VM. Abnormal sensitivity of human fibroblasts from xeroderma pigmentosum variants to transformation to anchorage independence by ultraviolet radiation. Cancer Res. 1986 Feb;46(2).489-92.
340. Vuillaume M, Calvayrac R, Best-Belpomme M, Tarroux P, Hubert M, Decroix Y, Sarasin A. Deficiency in the catalase activity of xeroderma pigmentosum cell and simian virus 40-transformed human cell extracts. Cancer Res. 1986 Feb;46(2).538-44.
341. Fujiwara Y, Ichihashi M, Uehara Y, Matsumoto A, Yamamoto Y, Kano Y, Tanakura Y. Xeroderma pigmentosum groups C and F. additional assignments and a review of the subjects in Japan. J Radiat Res. 1985 Dec;26(4).443-9.
342. Protić-Sabljić M, Kraemer KH. One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells. Proc Natl Acad Sci U S A. 1985 Oct;82(19).6622-6.
343. Morison WL, Bucana C, Hashem N, Kripke ML, Cleaver JE, German JL. Impaired immune function in patients with xeroderma pigmentosum. Cancer Res. 1985 Aug;45(8).3929-31.
344. Protić-Sabljić M, Whyte D, Fagan J, Howard BH, Gorman CM, Padmanabhan R, Kraemer KH. Quantification of expression of linked cloned genes in a simian virus 40-transformed xeroderma pigmentosum cell line. Mol Cell Biol. 1985 Jul;5(7).1685-93.
345. Johnson RT, Squires S, Elliott GC, Koch GL, Rainbow AJ. Xeroderma pigmentosum D-HeLa hybrids with low and high ultraviolet sensitivity associated with normal and diminished DNA repair ability, respectively. J Cell Sci. 1985 Jun;76.115-33.
346. Abrahams PJ, Huitema BA, van der EB AJ. Enhanced reactivation and enhanced mutagenesis of herpes simplex virus in normal human and xeroderma pigmentosum cells. Mol Cell Biol. 1984 Nov;4(11).2341-6.
347. Gupta PK, Sirover MA. Regulation of DNA repair in serum-stimulated xeroderma pigmentosum cells. J Cell Biol. 1984 Oct;99(4 Pt 1).1275-81.
348. Hurt MM, Moses RE. Abnormal response of xeroderma pigmentosum cells to bleomycin. Cancer Res. 1984 Oct;44(10).4396-402.
349. Legerski RJ, Brown DB, Peterson CA, Robberson DL. Transient complementation of xeroderma pigmentosum cells by microinjection of poly(A)+ RNA. Proc Natl Acad Sci U S A. 1984 Sep;81(18).5676-9.
350. Okui T, Fujiwara Y. Defective repair of tryptophan pyrolysate (Trp P-1 and Trp P-2) and aflatoxin B1 damage in xeroderma pigmentosum cells. J Radiat Res. 1983 Dec;24(4).356-63.
351. Hurt MM, Beaudet AL, Moses RE. Stable low molecular weight DNA in xeroderma pigmentosum cells. Proc Natl Acad Sci U S A. 1983 Nov;80(22).6987-91.
352. Kuhnlein U, Tsang SS, Lokken O, Tong S, Twa D. Cell lines from xeroderma pigmentosum complementation group A lack a single-stranded-DNA-binding activity. Biosci Rep. 1983 Jul;3(7).667-74.
353. de Jonge AJ, Vermeulen W, Klein B, Hoeijmakers JH. Microinjection of human cell extracts corrects xeroderma pigmentosum defect. EMBO J. 1983;2(5).637-41.
354. Smerdon MJ, Lan SY, Calza RE, Reeves R. Sodium butyrate stimulates DNA repair in UV-irradiated normal and xeroderma pigmentosum human fibroblasts. J Biol Chem. 1982 Nov 25;257(22).13441-7.
355. Welshimer K, Swift M. Congenital malformations and developmental disabilities in ataxia-telangiectasia, Fanconi anemia, and xeroderma pigmentosum families. Am J Hum Genet. 1982 Sep;34(5).781-93.
356. Petrusek RL, Uhlenhopp EL, Duteau N, Hurley LH. Reaction of anthramycin with DNA. Biological consequences of DNA damage in normal and xeroderma pigmentosum cell. J Biol Chem. 1982 Jun 10;257(11).6207-16.
357. Maher VM, Rowan LA, Silinskas KC, Kateley SA, McCormick JJ. Frequency of UV-induced neoplastic transformation of diploid human fibroblasts is higher in xeroderma pigmentosum cells than in normal cells. Proc Natl Acad Sci U S A. 1982 Apr;79(8).2613-7.
358. Mayne LV, Lehmann AR. Failure of RNA synthesis to recover after UV irradiation. an early defect in cells from individuals with Cockayne's syndrome and xeroderma pigmentosum. Cancer Res. 1982 Apr;42(4).1473-8.
359. Cleaver JE. Inactivation of ultraviolet repair in normal and xeroderma pigmentosum cells by methyl methanesulfonate. Cancer Res. 1982 Mar;42(3).860-3.
360. Miskin R, Ben-Ishai R. Induction of plasminogen activator by UV light in normal and xeroderma pigmentosum fibroblasts. Proc Natl Acad Sci U S A. 1981 Oct;78(10).6236-40.
361. Ozer HL, Slater ML, Dermody JJ, Mandel M. Replication of simian virus 40 DNA in normal human fibroblasts and in fibroblasts from xeroderma pigmentosum. J Virol. 1981 Aug;39(2).481-9.
362. McCurry LS, Jacobson MK. Poly(ADP-ribose) synthesis following DNA damage in cells heterozygous or homozygous for the xeroderma pigmentosum genotype. J Biol Chem. 1981 Jan 25;256(2).551-3.
363. Meneghini R, Cordeiro-Stone M, Schumacher RI. Size and frequency of gaps in newly synthesized DNA of xeroderma pigmentosum human cells irradiated with ultraviolet light. Biophys J. 1981 Jan;33(1).81-92.
364. Rainbow AJ. Reduced capacity to repair irradiated adenovirus in fibroblasts from xeroderma pigmentosum heterozygotes. Cancer Res. 1980 Nov;40(11).3945-9.
365. Hashem N, Bootsma D, Keijzer W, Greene A, Coriell L, Thomas G, Cleaver JE. Clinical characteristics, DNA repair, and complementation groups in xeroderma pigmentosum patients from Egypt. Cancer Res. 1980 Jan;40(1).13-8.
366. Hall JD, Tokuno SI. Enhanced transformation of xeroderma pigmentosum variant cells by ultraviolet light-irradiated simian virus 40. Cancer Res. 1979 Oct;39(10).4064-8.
367. Talley-Brown S, Millette RL. Gene expression of herpes simplex virus. I. Analysis of cytoplasmic RNAs in infected xeroderma pigmentosum cells. J Virol. 1979 Sep;31(3).733-40.
368. Glover TW, Chang CC, Trosko JE, Li SS. Ultraviolet light induction of diphtheria toxin-resistant mutants of normal and xeroderma pigmentosum human fibroblasts. Proc Natl Acad Sci U S A. 1979 Aug;76(8).3982-6.
369. Park SD, Cleaver JE. Postreplication repair. questions of its definition and possible alteration in xeroderma pigmentosum cell strains. Proc Natl Acad Sci U S A. 1979 Aug;76(8).3927-31.
370. Park SD, Cleaver JE. Recovery of DNA synthesis after ultraviolet irradiation of xeroderma pigmentosum cells depends on excision repair and is blocked by caffeine. Nucleic Acids Res. 1979 Mar;6(3).1151-9.
371. Ahmed FE, Setlow RB. DNA repair in xeroderma pigmentosum cells treated with combinations of ultraviolet radiation and N-acetoxy-2-acetylaminofluorene. Cancer Res. 1979 Feb;39(2 Pt 1).471-9.
372. Lynch HT, Frichot BC 3rd, Fisher J, Smith JL Jr, Lynch JF. Spontaneous regression of metastatic malignant melanoma in 2 sibs with xeroderma pigmentosum. J Med Genet. 1978 Oct;15(5).357-62.
373. Cheng WS, Tarone RE, Andrews AD, Whang-Peng JS, Robbins JH. Ultraviolet light-induced sister chromatid exchanges in xeroderma pigmentosum and in Cockayne's syndrome lymphocyte cell lines. Cancer Res. 1978 Jun;38(6).1601-9.
374. Smith CA, Hanawalt PC. Phage T4 endonuclease V stimulates DNA repair replication in isolated nuclei from ultraviolet-irradiated human cells, including xeroderma pigmentosum fibroblasts. Proc Natl Acad Sci U S A. 1978 Jun;75(6).2598-602.
375. D'Ambrosio SM, Setlow RB. Defective and enhanced postreplication repair in classical and variant xeroderma pigmentosum cells treated with N-acetoxy-2-acetylaminofluorene. Cancer Res. 1978 Apr;38(4).1147-53.
376. Andrews AD, Barrett SF, Robbins JH. Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation. Proc Natl Acad Sci U S A. 1978 Apr;75(4).1984-8.
377. Kuhnlein U, Lee B, Penhoet EE, Linn S. Xeroderma pigmentosum fibroblasts of the D group lack an apurinic DNA endonuclease species with a low apparent Km. Nucleic Acids Res. 1978 Mar;5(3).951-60.
378. Cook PR, Brazell IA, Pawsey SA, Giannelli F. Changes induced by ultraviolet light in the superhelical DNA of lymphocytes from subjects with xeroderma pigmentosum and normal controls. J Cell Sci. 1978 Feb;29.117-27.
379. Tohda H, Oikawa A, Katsuki T, Hinuma Y, Seiji M. A convenient method of establishing permanent lines of xeroderma pigmentosum cells. Cancer Res. 1978 Feb;38(2).253-6.
380. Tanaka K, Hayakawa H, Sekiguchi M, Okada Y. Specific action of T4 endonuclease V on damaged DNA in xeroderma pigmentosum cells in vivo. Proc Natl Acad Sci U S A. 1977 Jul;74(7).2958-62.
381. Takebe H, Miki Y, Kozuka T, Furuyama JI, Tanaka K. DNA repair characteristics and skin cancers of xeroderma pigmentosum patients in Japan. Cancer Res. 1977 Feb;37(2).490-5.
382. Freedman J. Xeroderma pigmentosum and band-shaped nodular corneal dystrophy. Br J Ophthalmol. 1977 Feb;61(2).96-100.
383. Bertazzoni U, Stefanini M, Pedrali-Noy G, Nuzzo F, Falaschi A. Levels of DNA polymerase-alpha and beta in normal and xeroderma pigmentosum fibroblasts. Nucleic Acids Res. 1977 Jan;4(1).141-8.
384. Chang KS. Susceptibility of xeroderma pigmentosum cells to transformation by murine and feline sarcoma viruses. Cancer Res. 1976 Sep;36(9 pt.1).3294-9.
385. Mortelmans K, Friedberg EC, Slor H, Thomas G, Cleaver JE. Defective thymine dimer excision by cell-free extracts of xeroderma pigmentosum cells. Proc Natl Acad Sci U S A. 1976 Aug;73(8).2757-61.
386. Kuhnlein U, Penhoet EE, Linn S. An altered apurinic DNA endonuclease activity in group A and group D xeroderma pigmentosum fibroblasts. Proc Natl Acad Sci U S A. 1976 Apr;73(4).1169-73.
387. Giannelli F, Pawsey SA. DNA repair synthesis in human heterokaryons. III. The rapid and slow complementing varieties of xeroderma pigmentosum. J Cell Sci. 1976 Jan;20(1).207-13.
388. Fornace AJ Jr, Kohn KW, Kann HE Jr. DNA single-strand breaks during repair of UV damage in human fibroblasts and abnormalities of repair in xeroderma pigmentosum. Proc Natl Acad Sci U S A. 1976 Jan;73(1).39-43.
389. Tanaka K, Sekiguchi M, Okada Y. Restoration of ultraviolet-induced unscheduled DNA synthesis of xeroderma pigmentosum cells by the concomitant treatment with bacteriophage T4 endonuclease V and HVJ (Sendai virus). Proc Natl Acad Sci U S A. 1975 Oct;72(10).4071-5.
390. Wolff S, Bodycote J, Thomas GH, Cleaver JE. Sister chromatid exchange in xeroderma pigmentosum cells that are defective in DNA excision repair or post-replication repair. Genetics. 1975 Oct;81(2).349-55.
391. Akiba H, Kato T, Nakano H, Seiji M. Defective DNA repair replication in xeroderma pigmentosum fibroblasts and DNA repair of somatic cell hybrids after UV irradiation. Tohoku J Exp Med. 1975 Sep;117(1).1-13.
392. Lehmann AR, Kirk-Bell S, Arlett CF, Paterson MC, Lohman PH, de Weerd-Kastelein EA, Bootsma D. Xeroderma pigmentosum cells with normal levels of excision repair have a defect in DNA synthesis after UV-irradiation. Proc Natl Acad Sci U S A. 1975 Jan;72(1).219-23.
393. Sutherland BM, Rice M, Wagner EK. Xeroderma pigmentosum cells contain low levels of photoreactivating enzyme. Proc Natl Acad Sci U S A. 1975 Jan;72(1).103-7.
394. Kraemer KH, Coon HG, Petinga RA, Barrett SF, Rahe AE, Robbins JH. Genetic heterogeneity in xeroderma pigmentosum. complementation groups and their relationship to DNA repair rates. Proc Natl Acad Sci U S A. 1975 Jan;72(1).59-63.
395. Day RS 3rd. Studies on repair of adenovirus 2 by human fibroblasts using normal, xeroderma pigmentosum, and xeroderma pigmentosum heterozygous strains. Cancer Res. 1974 Aug;34(8).1965-70.
396. Fujiwara Y, Kondo T. Postreplication repair of ultraviolet damage to DNA in xeroderma pigmentosum, other human and mouse cells in culture. J Radiat Res. 1974 Jun;15(2).81-9.
397. Giannelli F, Pawsey SA. DNA repair synthesis in human heterokaryons. II. A test for heterozygosity in xeroderma pigmentosum and some insight into the structure of the defective enzyme. J Cell Sci. 1974 Jun;15(1).163-76.
398. Pedrini AM, Dalpra L, Ciarrocchi G, Noy GC, Spadari S, Nuzzo F, Falaschi A. Levels of some enzymes acting on DNA in xeroderma pigmentosum. Nucleic Acids Res. 1974 Feb;1(2).193-202.
399. Robbins JH, Burk PG. Relationship of DNA repair to carcinogenesis in xeroderma pigmentosum. Cancer Res. 1973 May;33(5).929-35.
400. Cleaver JE. DNA repair with purines and pyrimidines in radiation- and carcinogen-damaged normal and xeroderma pigmentosum human cells. Cancer Res. 1973 Feb;33(2).362-9.
401. Buhl SN, Stillman RM, Setlow RB, Regan JD. DNA chain elongation and joining in normal human and xeroderma pigmentosum cells after ultraviolet irradiation. Biophys J. 1972 Sep;12(9).1183-91.
402. Kobza A, Giannelli F. Xeroderma pigmentosum. Proc R Soc Med. 1972 Jun;65(6).529-30.
403. Sood GC, Sofat BK, Chandel RD, Lal S, Logani KB. Xeroderma pigmentosum with ocular involvement in a Nepali. Indian J Ophthalmol. 1972 Mar;20(1).31-3.
404. Cleaver JE. Enzyme defect in xeroderma pigmentosum. Calif Med. 1970 Oct;113(4).40.
405. Moynahan EJ. XTE syndrome (xeroderma, talipes and enamel defect). a new heredo-familial syndrome. Two cases. Homozygous inheritance of a dominant gene. Proc R Soc Med. 1970 May;63(5).447-8.
406. Setlow RB, Regan JD, German J, Carrier WL. Evidence that xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA. Proc Natl Acad Sci U S A. 1969 Nov;64(3).1035-41.
407. Cleaver JE. Xeroderma pigmentosum. a human disease in which an initial stage of DNA repair is defective. Proc Natl Acad Sci U S A. 1969 Jun;63(2).428-35.
408. LEMAIRE M, GAUMOND E. [XERODERMA PIGMENTOSUM. 8 CASES OF DIFFERENT EVOLUTION IN 2 FAMILIES]. Can Med Assoc J. 1965 Feb 20;92.406-12. French.
409. SEVEL D. XERODERMA PIGMENTOSUM WITH OCULAR COMPLICATIONS. Br J Ophthalmol. 1963 Nov;47.687-9.
410. Moynahan EJ. Xeroderma Pigmentosa, with Keratinizing Epithelioma of Lower Lip. Proc R Soc Med. 1962 Dec;55(12).1076.
411. Schwartz B. Xeroderma Pigmentosum. Proc R Soc Med. 1957 Jul;50(7).474-5.
412. Gold SC. Xeroderma Pigmentosum. Proc R Soc Med. 1957 Jul;50(7).474.
413. SIVASUBRAMANIAM P. Keratoplasty in xeroderma pigmentosum. Br J Ophthalmol. 1956 Sep;40(9).549-52.
414. ITO M. Genetical studies on skin diseases. I. Ephelides, dyschromatosis symmetrica hereditaria and xeroderma pigmentosum. Tohoku J Exp Med. 1950 Dec 25;53(1/2).69-76.
415. SAMMAN PD. Generalized pigmentation with linear atrophy; xeroderma pigmentosum? Proc R Soc Med. 1949 Mar;42(3).136.
416. Saebø J. XERODERMA PIGMENTOSUM WITH AFFECTION OF THE EYE. Br J Ophthalmol. 1948 Jul;32(7).398-411.
417. KOLLER PC. Inheritance of xeroderma and its chromosome mechanism. Br J Cancer. 1948 Jun;2(2).149-55.
418. Gray AM. Xeroderma Pigmentosum. Proc R Soc Med. 1938 Jan;31(3).265-6.
419. Councilman WT, Magrath GB. The Lesions of the Skin and the tumor formations in Xeroderma Pigmentosum. J Med Res. 1909 Oct;21(3).331-356.5.
420. Hunter WB. Notes of Three Cases of Xeroderma Pigmentosum, or Dermatosis Kaposi. Br Med J. 1889 Jul 13;2(1489).69-71.
421. Anderson TM. Note of a Rare Form of Skin Disease. Xeroderma Pigmentosum. Br Med J. 1889 Jun 8;1(1484).1284-5.
422. Crocker HR. Three cases of Xeroderma Pigmentosum (Kaposi) or Atrophoderma Pigmentosum. Med Chir Trans. 1884;67.169-188.5.
|
Bookmark this post:
|
|
Posts
0 comments:
Post a Comment